{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:18:46Z","timestamp":1791944326030,"version":"4.3.4"},"reference-count":739,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T00:00:00Z","timestamp":1620345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01-HD083493"],"award-info":[{"award-number":["U01-HD083493"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders affecting cortisol biosynthesis. Reduced activity of an enzyme required for cortisol production leads to chronic overstimulation of the adrenal cortex and accumulation of precursors proximal to the blocked enzymatic step. The most common form of CAH is caused by steroid 21-hydroxylase deficiency due to mutations in CYP21A2. Since the last publication summarizing CAH in Endocrine Reviews in 2000, there have been numerous new developments. These include more detailed understanding of steroidogenic pathways, refinements in neonatal screening, improved diagnostic measurements utilizing chromatography and mass spectrometry coupled with steroid profiling, and improved genotyping methods. Clinical trials of alternative medications and modes of delivery have been recently completed or are under way. Genetic and cell-based treatments are being explored. A large body of data concerning long-term outcomes in patients affected by CAH, including psychosexual well-being, has been enhanced by the establishment of disease registries. This review provides the reader with current insights in CAH with special attention to these new developments.<\/jats:p>","DOI":"10.1210\/endrev\/bnab016","type":"journal-article","created":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T08:26:20Z","timestamp":1620462380000},"page":"91-159","source":"Crossref","is-referenced-by-count":502,"title":["Congenital Adrenal Hyperplasia\u2014Current Insights in Pathophysiology, Diagnostics, and Management"],"prefix":"10.1210","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0181-0403","authenticated-orcid":false,"given":"Hedi L","family":"Claahsen - van der Grinten","sequence":"first","affiliation":[{"name":"Department of Pediatric Endocrinology, Radboud University Medical Centre, Amalia Childrens Hospital, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0565-8325","authenticated-orcid":false,"given":"Phyllis W","family":"Speiser","sequence":"additional","affiliation":[{"name":"Cohen Children\u2019s Medical Center of NY, Feinstein Institute, Northwell Health, Zucker School of Medicine, New Hyde Park, NY 11040, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Faisal","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Developmental Endocrinology Research Group, School of Medicine Dentistry & Nursing, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5106-9719","authenticated-orcid":false,"given":"Wiebke","family":"Arlt","sequence":"additional","affiliation":[{"name":"Institute of Metabolism and Systems Research (IMSR), College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK"},{"name":"Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J","family":"Auchus","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology, and Diabetes, Departments of Internal Medicine and Pharmacology, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5622-6987","authenticated-orcid":false,"given":"Henrik","family":"Falhammar","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Intitutet, Stockholm, Sweden"},{"name":"Department of Endocrinology, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa E","family":"Fl\u00fcck","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology, Diabetology and Metabolism, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Guasti","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, William Harvey Research Institute, Bart\u2019s and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1338-5192","authenticated-orcid":false,"given":"Angela","family":"Huebner","sequence":"additional","affiliation":[{"name":"Division of Paediatric Endocrinology and Diabetology, Department of Paediatrics, Universit\u00e4tsklinikum Dresden, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara B M","family":"Kortmann","sequence":"additional","affiliation":[{"name":"Radboud University Medical Centre, Amalia Childrens Hospital, Department of Pediatric Urology, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Krone","sequence":"additional","affiliation":[{"name":"Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK"},{"name":"Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah P","family":"Merke","sequence":"additional","affiliation":[{"name":"National Institutes of Health Clinical Center and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter L","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Center for Reproductive Sciences, and Institute for Human Genetics, University of California, San Francisco, CA 94143, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nordenstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Women\u2019s and Children\u2019s Health, Karolinska Institutet, Stockholm, Sweden"},{"name":"Pediatric Endocrinology, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Reisch","sequence":"additional","affiliation":[{"name":"Medizinische Klinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E","family":"Sandberg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Susan B. Meister Child Health Evaluation and Research Center, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nike M M L","family":"Stikkelbroeck","sequence":"additional","affiliation":[{"name":"Radboud University Medical Centre, Department of Endocrinology, Nijmegen, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8462-7753","authenticated-orcid":false,"given":"Philippe","family":"Touraine","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Reproductive Medicine, Center for Rare Endocrine Diseases of Growth and Development, Center for Rare Gynecological Diseases, H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re, Sorbonne University Medicine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustini","family":"Utari","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Department of Pediatrics, Faculty of Medicine, Diponegoro University, Semarang, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan A","family":"Wudy","sequence":"additional","affiliation":[{"name":"Steroid Research & Mass Spectrometry Unit, Laboratory of Translational Hormone Analytics, Division of Paediatric Endocrinology & Diabetology, Justus Liebig University, Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6262-0289","authenticated-orcid":false,"given":"Perrin C","family":"White","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, UT Southwestern Medical Center, Dallas TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,5,7]]},"reference":[{"issue":"3","key":"2022011306531787300_CIT0001","first-page":"245","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"21","author":"White","year":"2000","journal-title":"Endocr Rev."},{"issue":"1","key":"2022011306531787300_CIT0002","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S2213-8587(13)70007-X","article-title":"One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study","volume":"1","author":"Gidl\u00f6f","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"2022011306531787300_CIT0003","first-page":"73","article-title":"Neonatal screening for congenital adrenal hyperplasia: experience and results in Argentina","volume":"21","author":"Gru\u00f1ieiro-Papendieck","year":"2008","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"10","key":"2022011306531787300_CIT0004","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1440-1754.2008.01383.x","article-title":"Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia","volume":"44","author":"Gleeson","year":"2008","journal-title":"J Paediatr Child Health."},{"issue":"11","key":"2022011306531787300_CIT0005","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1440-1754.2012.02584.x","article-title":"Ethnic and gender differences in rates of congenital adrenal hyperplasia in Western Australia over a 21 year period","volume":"48","author":"Shetty","year":"2012","journal-title":"J Paediatr Child Health."},{"issue":"7","key":"2022011306531787300_CIT0006","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1590\/0004-2730000003310","article-title":"Ten-year evaluation of a Neonatal Screening Program for congenital adrenal hyperplasia","volume":"58","author":"Nascimento","year":"2014","journal-title":"Arq Bras Endocrinol Metabol."},{"issue":"5","key":"2022011306531787300_CIT0007","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1515\/JPEM.2008.21.5.455","article-title":"The actual incidence of congenital adrenal hyperplasia in Brazil may not be as high as inferred\u2013an estimate based on a public neonatal screening program in the state of Goi\u00e1s","volume":"21","author":"Silveira","year":"2008","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0008","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jped.2013.09.007","article-title":"A three-year follow-up of congenital adrenal hyperplasia newborn screening","volume":"90","author":"Pezzuti","year":"2014","journal-title":"J Pediatr (Rio J)."},{"issue":"1","key":"2022011306531787300_CIT0009","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12887-016-0772-x","article-title":"Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108","volume":"17","author":"Kopacek","year":"2017","journal-title":"BMC Pediatr."},{"issue":"2","key":"2022011306531787300_CIT0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/0969141315597715","article-title":"The status of neonatal screening in China, 2013","volume":"23","author":"Zhong","year":"2016","journal-title":"J Med Screen."},{"issue":"3","key":"2022011306531787300_CIT0011","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/jpem-2018-0342","article-title":"A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing","volume":"32","author":"Gong","year":"2019","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"5","key":"2022011306531787300_CIT0012","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000245933","article-title":"Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia between 1995 and 2006","volume":"72","author":"Dumic","year":"2009","journal-title":"Horm Res."},{"key":"2022011306531787300_CIT0013","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cca.2013.02.020","article-title":"Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience","volume":"421","author":"Gonz\u00e1lez","year":"2013","journal-title":"Clin Chim Acta."},{"issue":"2","key":"2022011306531787300_CIT0014","doi-asserted-by":"crossref","first-page":"153","DOI":"10.21101\/cejph.a5441","article-title":"Epidemiology of rare diseases detected by newborn screening in the Czech Republic","volume":"27","author":"David","year":"2019","journal-title":"Cent Eur J Public Health."},{"issue":"2","key":"2022011306531787300_CIT0015","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archpediatrics.2011.774","article-title":"Efficiency of neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency in children born in mainland France between 1996 and 2003","volume":"166","author":"Coulm","year":"2012","journal-title":"Arch Pediatr Adolesc Med."},{"issue":"5","key":"2022011306531787300_CIT0016","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1055\/s-0035-1554639","article-title":"Classic congenital adrenal hyperplasia due to 21-hydroxylase-deficiency: 13 years of neonatal screening and follow-up in Bavaria","volume":"227","author":"Odenwald","year":"2015","journal-title":"Klin Padiatr."},{"issue":"1","key":"2022011306531787300_CIT0017","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1515\/jpem-2015-0009","article-title":"Current and future perspective of newborn screening: an Indian scenario","volume":"29","author":"Kaur","year":"2016","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"8","key":"2022011306531787300_CIT0018","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1210\/jc.2018-02468","article-title":"Combined gestational age- and birth weight-adjusted cutoffs for newborn screening of congenital adrenal hyperplasia","volume":"104","author":"Pode-Shakked","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0019","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1297\/cpe.23.35","article-title":"Results from 28 years of newborn screening for congenital adrenal hyperplasia in Sapporo","volume":"23","author":"Morikawa","year":"2014","journal-title":"Clin Pediatr Endocrinol."},{"key":"2022011306531787300_CIT0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12887-015-0529-y","article-title":"Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study","volume":"15","author":"Tsuji","year":"2015","journal-title":"BMC Pediatr."},{"issue":"8","key":"2022011306531787300_CIT0021","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1080\/0092623X.2019.1610123","article-title":"Sexuality in adults with differences\/disorders of sex development (DSD): findings from the dsd-LIFE Study","volume":"45","author":"Kreukels","year":"2019","journal-title":"J Sex Marital Ther."},{"issue":"3","key":"2022011306531787300_CIT0022","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1210\/jc.2014-3168","article-title":"Newborn screening for congenital adrenal hyperplasia in New Zealand, 1994-2013","volume":"100","author":"Heather","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0023","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4274\/jcrpe.galenos.2020.2019.0182","article-title":"Neonatal screening for congenital adrenal hyperplasia in Turkey: outcomes of extended pilot study in 241","volume":"12","author":"G\u00fcran","year":"2020","journal-title":"J Clin Res Pediatr Endocrinol."},{"issue":"1","key":"2022011306531787300_CIT0024","doi-asserted-by":"crossref","first-page":"17","DOI":"10.26719\/2014.20.1.17","article-title":"Expanding the comprehensive national neonatal screening programme in the United Arab Emirates from 1995 to 2011","volume":"20","author":"Al Hosani","year":"2014","journal-title":"East Mediterr Health J."},{"issue":"11-12","key":"2022011306531787300_CIT0025","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1515\/jpem-2012-0113","article-title":"Apparent mineralocorticoid excess syndrome: report of one family with three affected children","volume":"25","author":"Al-Harbi","year":"2012","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0026","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12687-015-0236-2","article-title":"Ethics, genetics and public policies in Uruguay: newborn and infant screening as a paradigm","volume":"6","author":"Larrandaburu","year":"2015","journal-title":"J Community Genet."},{"issue":"7","key":"2022011306531787300_CIT0027","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1210\/jc.2004-2136","article-title":"Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight","volume":"90","author":"van der Kamp","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0028","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1203\/PDR.0b013e3181b1bbec","article-title":"Physiological partial aldosterone resistance in human newborns","volume":"66","author":"Martinerie","year":"2009","journal-title":"Pediatr Res."},{"issue":"12","key":"2022011306531787300_CIT0029","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s00467-013-2666-6","article-title":"Developmental changes in renal tubular transport-an overview","volume":"30","author":"Gattineni","year":"2015","journal-title":"Pediatr Nephrol."},{"issue":"3","key":"2022011306531787300_CIT0030","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz142","article-title":"The external genitalia score (EGS): a European multicenter validation study","volume":"105","author":"van der Straaten","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"6352","key":"2022011306531787300_CIT0031","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1126\/science.aai9136","article-title":"Elimination of the male reproductive tract in the female embryo is promoted by COUP-TFII in mice","volume":"357","author":"Zhao","year":"2017","journal-title":"Science."},{"issue":"13","key":"2022011306531787300_CIT0032","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMra1909786","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"383","author":"Merke","year":"2020","journal-title":"N Engl J Med."},{"issue":"9","key":"2022011306531787300_CIT0033","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1210\/jc.2009-2616","article-title":"Clinical review: adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis","volume":"95","author":"Muthusamy","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022011306531787300_CIT0034","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000333696","article-title":"Adrenarche and puberty in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"76","author":"V\u00f6lkl","year":"2011","journal-title":"Horm Res Paediatr."},{"issue":"1","key":"2022011306531787300_CIT0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.fertnstert.2018.11.037","article-title":"Classic congenital adrenal hyperplasia and its impact on reproduction","volume":"111","author":"Gomes","year":"2019","journal-title":"Fertil Steril."},{"issue":"3","key":"2022011306531787300_CIT0036","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000492082","article-title":"Prevalence of testicular adrenal rest tumor and factors associated with its development in congenital adrenal hyperplasia","volume":"90","author":"Mendes-Dos-Santos","year":"2018","journal-title":"Horm Res Paediatr."},{"issue":"1","key":"2022011306531787300_CIT0037","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12020-015-0656-0","article-title":"Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome","volume":"50","author":"Falhammar","year":"2015","journal-title":"Endocrine."},{"issue":"11","key":"2022011306531787300_CIT0038","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/gim.2017.46","article-title":"Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US Ashkenazi Jews and Caucasians","volume":"19","author":"Hannah-Shmouni","year":"2017","journal-title":"Genet Med."},{"issue":"1","key":"2022011306531787300_CIT0039","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr Rev."},{"issue":"Pt A","key":"2022011306531787300_CIT0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jsbmb.2016.03.009","article-title":"Disorders in the initial steps of steroid hormone synthesis","volume":"165","author":"Miller","year":"2017","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"1","key":"2022011306531787300_CIT0041","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biolre\/ioy102","article-title":"Current knowledge on the acute regulation of steroidogenesis","volume":"99","author":"Selvaraj","year":"2018","journal-title":"Biol Reprod."},{"issue":"11","key":"2022011306531787300_CIT0042","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.tem.2017.09.002","article-title":"Steroidogenesis: unanswered questions","volume":"28","author":"Miller","year":"2017","journal-title":"Trends Endocrinol Metab."},{"issue":"25","key":"2022011306531787300_CIT0043","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJM199612193352503","article-title":"The pathophysiology and genetics of congenital lipoid adrenal hyperplasia","volume":"335","author":"Bose","year":"1996","journal-title":"N Engl J Med."},{"issue":"5205","key":"2022011306531787300_CIT0044","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1126\/science.7892608","article-title":"Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis","volume":"267","author":"Lin","year":"1995","journal-title":"Science."},{"issue":"12","key":"2022011306531787300_CIT0045","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1210\/jc.2006-1565","article-title":"Nonclassic congenital lipoid adrenal hyperplasia: a new disorder of the steroidogenic acute regulatory protein with very late presentation and normal male genitalia","volume":"91","author":"Baker","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0046","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1210\/jc.2008-1118","article-title":"A novel homozygous mutation in CYP11A1 gene is associated with late-onset adrenal insufficiency and hypospadias in a 46,XY patient","volume":"94","author":"Rubtsov","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0047","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1210\/jc.2010-1828","article-title":"Partial defect in the cholesterol side-chain cleavage enzyme P450scc (CYP11A1) resembling nonclassic congenital lipoid adrenal hyperplasia","volume":"96","author":"Sahakitrungruang","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2022011306531787300_CIT0048","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa557","article-title":"Clinical features of 57 patients with lipoid congenital adrenal hyperplasia: criteria for nonclassic form revisited","volume":"105","author":"Ishii","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022011306531787300_CIT0049","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1210\/en.2005-0096","article-title":"Minireview: regulation of steroidogenesis by electron transfer","volume":"146","author":"Miller","year":"2005","journal-title":"Endocrinology."},{"issue":"4","key":"2022011306531787300_CIT0050","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ajhg.2017.09.007","article-title":"FDXR mutations cause sensorial neuropathies and expand the spectrum of mitochondrial Fe-S-synthesis diseases","volume":"101","author":"Paul","year":"2017","journal-title":"Am J Hum Genet."},{"issue":"24","key":"2022011306531787300_CIT0051","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1093\/hmg\/ddx377","article-title":"Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy","volume":"26","author":"Peng","year":"2017","journal-title":"Hum Mol Genet."},{"issue":"12","key":"2022011306531787300_CIT0052","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/s10038-018-0515-y","article-title":"Biallelic mutations in FDXR cause neurodegeneration associated with inflammation","volume":"63","author":"Slone","year":"2018","journal-title":"J Hum Genet."},{"issue":"4","key":"2022011306531787300_CIT0053","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/er.2002-0050","article-title":"Molecular biology of the 3beta-hydroxysteroid dehydrogenase\/delta5-delta4 isomerase gene family","volume":"26","author":"Simard","year":"2005","journal-title":"Endocr Rev."},{"issue":"45","key":"2022011306531787300_CIT0054","doi-asserted-by":"crossref","first-page":"42795","DOI":"10.1074\/jbc.M208537200","article-title":"Structure\/function relationships responsible for the kinetic differences between human type 1 and type 2 3beta-hydroxysteroid dehydrogenase and for the catalysis of the type 1 activity","volume":"277","author":"Thomas","year":"2002","journal-title":"J Biol Chem."},{"issue":"6","key":"2022011306531787300_CIT0055","first-page":"2104","article-title":"Medroxyprogesterone acetate and dexamethasone are competitive inhibitors of different human steroidogenic enzymes","volume":"84","author":"Lee","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2022011306531787300_CIT0056","first-page":"4410","article-title":"New insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes","volume":"84","author":"Moisan","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0057","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1210\/jc.2004-1552","article-title":"Refining hormonal diagnosis of type II 3beta-hydroxysteroid dehydrogenase deficiency in patients with premature pubarche and hirsutism based on HSD3B2 genotyping","volume":"90","author":"Mermejo","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022011306531787300_CIT0058","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000336004","article-title":"A novel homozygous Q334X mutation in the HSD3B2 gene causing classic 3\u03b2-hydroxysteroid dehydrogenase deficiency: an unexpected diagnosis after a positive newborn screen for 21-hydroxylase deficiency","volume":"77","author":"Jeandron","year":"2012","journal-title":"Horm Res Paediatr."},{"issue":"5","key":"2022011306531787300_CIT0059","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-15-0599","article-title":"Human 3\u03b2-hydroxysteroid dehydrogenase deficiency seems to affect fertility but may not harbor a tumor risk: lesson from an experiment of nature","volume":"173","author":"Burckhardt","year":"2015","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2022011306531787300_CIT0060","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1074\/jbc.273.6.3158","article-title":"Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer","volume":"273","author":"Auchus","year":"1998","journal-title":"J Biol Chem."},{"issue":"8","key":"2022011306531787300_CIT0061","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1210\/jc.2003-030143","article-title":"The 17, 20-lyase activity of cytochrome p450c17 from human fetal testis favors the delta5 steroidogenic pathway","volume":"88","author":"Fl\u00fcck","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022011306531787300_CIT0062","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0889-8529(08)70021-5","article-title":"The genetics, pathophysiology, and management of human deficiencies of P450c17","volume":"30","author":"Auchus","year":"2001","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"1","key":"2022011306531787300_CIT0063","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/jc.2011-2161","article-title":"The syndrome of 17,20 lyase deficiency","volume":"97","author":"Miller","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0064","doi-asserted-by":"crossref","first-page":"E465","DOI":"10.1210\/jc.2011-2413","article-title":"A missense mutation in the human cytochrome b5 gene causes 46,XY disorder of sex development due to true isolated 17,20 lyase deficiency","volume":"97","author":"Idkowiak","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0065","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.fertnstert.2013.11.011","article-title":"Fertility in patients with genetic deficiencies of cytochrome P450c17 (CYP17A1): combined 17-hydroxylase\/17,20-lyase deficiency and isolated 17,20-lyase deficiency","volume":"101","author":"Marsh","year":"2014","journal-title":"Fertil Steril."},{"issue":"3","key":"2022011306531787300_CIT0066","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ng1300","article-title":"Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome","volume":"36","author":"Fl\u00fcck","year":"2004","journal-title":"Nat Genet."},{"issue":"1","key":"2022011306531787300_CIT0067","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1210\/jc.2004-0810","article-title":"Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and\/or impaired steroidogenesis: molecular and clinical studies in 10 patients","volume":"90","author":"Fukami","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022011306531787300_CIT0068","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1086\/429417","article-title":"Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis","volume":"76","author":"Huang","year":"2005","journal-title":"Am J Hum Genet."},{"issue":"2","key":"2022011306531787300_CIT0069","doi-asserted-by":"crossref","first-page":"E257","DOI":"10.1210\/jc.2011-0640","article-title":"Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency","volume":"97","author":"Krone","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0070","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1210\/clinem\/dgz255","article-title":"P450 oxidoreductase deficiency: a systematic review and meta-analysis of genotypes, phenotypes, and their relationships","volume":"105","author":"Dean","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"9427","key":"2022011306531787300_CIT0071","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(04)16503-3","article-title":"Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study","volume":"363","author":"Arlt","year":"2004","journal-title":"Lancet."},{"issue":"5","key":"2022011306531787300_CIT0072","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1210\/jc.2008-2816","article-title":"Cytochrome P450 oxidoreductase deficiency: identification and characterization of biallelic mutations and genotype-phenotype correlations in 35 Japanese patients","volume":"94","author":"Fukami","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2022011306531787300_CIT0073","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1210\/jc.2008-0051","article-title":"Homozygous mutation G539R in the gene for P450 oxidoreductase in a family previously diagnosed as having 17,20-lyase deficiency","volume":"93","author":"Hershkovitz","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022011306531787300_CIT0074","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ajhg.2011.09.015","article-title":"Craniosynostosis and multiple skeletal anomalies in humans and zebrafish result from a defect in the localized degradation of retinoic acid","volume":"89","author":"Laue","year":"2011","journal-title":"Am J Hum Genet."},{"issue":"6","key":"2022011306531787300_CIT0075","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1530\/EJE-10-0764","article-title":"Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency","volume":"163","author":"Tomalik-Scharte","year":"2010","journal-title":"Eur J Endocrinol."},{"issue":"12","key":"2022011306531787300_CIT0076","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1210\/jc.2009-1460","article-title":"Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients","volume":"94","author":"Sahakitrungruang","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0077","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ng1097-201","article-title":"The genetic and functional basis of isolated 17,20-lyase deficiency","volume":"17","author":"Geller","year":"1997","journal-title":"Nat Genet."},{"issue":"7","key":"2022011306531787300_CIT0078","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1210\/jc.2005-2460","article-title":"Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone","volume":"91","author":"Homma","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"44","key":"2022011306531787300_CIT0079","doi-asserted-by":"crossref","first-page":"22294","DOI":"10.1073\/pnas.1906623116","article-title":"Alternative pathway androgen biosynthesis and human fetal female virilization","volume":"116","author":"Reisch","year":"2019","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"26","key":"2022011306531787300_CIT0080","doi-asserted-by":"crossref","first-page":"14632","DOI":"10.1073\/pnas.2003154117","article-title":"Inhibition of placental CYP19A1 activity remains as a valid hypothesis for 46,XX virilization in P450 oxidoreductase deficiency","volume":"117","author":"Fl\u00fcck","year":"2020","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"12","key":"2022011306531787300_CIT0081","first-page":"4677","article-title":"Estrogen: consequences and implications of human mutations in synthesis and action","volume":"84","author":"Grumbach","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"issue":"26","key":"2022011306531787300_CIT0082","doi-asserted-by":"crossref","first-page":"14634","DOI":"10.1073\/pnas.2007695117","article-title":"Reply to Fl\u00fcck","volume":"117","author":"Reisch","year":"2020","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"2022011306531787300_CIT0083","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1073\/pnas.0711621105","article-title":"Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations","volume":"105","author":"Huang","year":"2008","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"7","key":"2022011306531787300_CIT0084","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1210\/jc.2008-0304","article-title":"The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency","volume":"93","author":"Gomes","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022011306531787300_CIT0085","first-page":"421","article-title":"Disorders of steroid 11 beta-hydroxylase isozymes","volume":"15","author":"White","year":"1994","journal-title":"Endocr Rev."},{"issue":"5","key":"2022011306531787300_CIT0086","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41574-020-0336-x","article-title":"11-Oxygenated androgens in health and disease","volume":"16","author":"Turcu","year":"2020","journal-title":"Nat Rev Endocrinol."},{"issue":"10","key":"2022011306531787300_CIT0087","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1210\/mend-5-10-1513","article-title":"The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex","volume":"5","author":"Curnow","year":"1991","journal-title":"Mol Endocrinol."},{"issue":"11","key":"2022011306531787300_CIT0088","first-page":"3996","article-title":"Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol","volume":"83","author":"Mulatero","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"issue":"4 Pt 1","key":"2022011306531787300_CIT0089","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1542\/peds.101.4.583","article-title":"Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia","volume":"101","author":"Therrell","year":"1998","journal-title":"Pediatrics."},{"issue":"1-2","key":"2022011306531787300_CIT0090","first-page":"7","article-title":"Integrated view on 17 \u03b2 -hydroxysteroid dehydrogenases","volume":"301","author":"Moeller","year":"2009","journal-title":"Mol Cell Biol."},{"issue":"3","key":"2022011306531787300_CIT0091","first-page":"281","article-title":"Molecular endocrinology of hydroxysteroid dehydrogenases","volume":"18","author":"Penning","year":"1997","journal-title":"Endocr Rev."},{"issue":"34","key":"2022011306531787300_CIT0092","doi-asserted-by":"crossref","first-page":"20458","DOI":"10.1016\/S0021-9258(19)47083-X","article-title":"Regulation of the gene for estrogenic 17-ketosteroid reductase lying on chromosome 17cen----q25","volume":"264","author":"Tremblay","year":"1989","journal-title":"J Biol Chem."},{"issue":"7","key":"2022011306531787300_CIT0093","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1043-2760(98)00066-6","article-title":"17beta-hydroxysteroid dehydrogenases: physiological roles in health and disease","volume":"9","author":"Moghrabi","year":"1998","journal-title":"Trends Endocrinol Metab."},{"issue":"5","key":"2022011306531787300_CIT0094","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00005792-200009000-00003","article-title":"Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase 3 deficiency. Diagnosis, psychological evaluation, and management","volume":"79","author":"Mendonca","year":"2000","journal-title":"Medicine (Baltimore)."},{"issue":"Pt 1","key":"2022011306531787300_CIT0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/bj3510067","article-title":"Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones","volume":"351","author":"Penning","year":"2000","journal-title":"Biochem J."},{"issue":"6","key":"2022011306531787300_CIT0096","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2008-2374","article-title":"Type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis","volume":"94","author":"Nakamura","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"25","key":"2022011306531787300_CIT0097","doi-asserted-by":"crossref","first-page":"15959","DOI":"10.1074\/jbc.272.25.15959","article-title":"Expression cloning and characterization of oxidative 17beta- and 3alpha-hydroxysteroid dehydrogenases from rat and human prostate","volume":"272","author":"Biswas","year":"1997","journal-title":"J Biol Chem."},{"issue":"2","key":"2022011306531787300_CIT0098","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ajhg.2011.06.009","article-title":"Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation","volume":"89","author":"Fl\u00fcck","year":"2011","journal-title":"Am J Hum Genet."},{"issue":"3","key":"2022011306531787300_CIT0099","first-page":"342","article-title":"Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis","volume":"15","author":"Simpson","year":"1994","journal-title":"Endocr Rev."},{"issue":"1","key":"2022011306531787300_CIT0100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0889-8529(08)70027-6","article-title":"Pregnancy outcomes in women with congenital virilizing adrenal hyperplasia","volume":"30","author":"Lo","year":"2001","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"1","key":"2022011306531787300_CIT0101","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1210\/jc.2008-1174","article-title":"Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency","volume":"94","author":"Gomes","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"36","key":"2022011306531787300_CIT0102","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1021\/bi300895w","article-title":"Minor activities and transition state properties of the human steroid hydroxylases cytochromes P450c17 and P450c21, from reactions observed with deuterium-labeled substrates","volume":"51","author":"Yoshimoto","year":"2012","journal-title":"Biochemistry."},{"issue":"13","key":"2022011306531787300_CIT0103","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1074\/jbc.M111.323501","article-title":"Three-dimensional structure of steroid 21-hydroxylase (cytochrome P450 21A2) with two substrates reveals locations of disease-associated variants","volume":"287","author":"Zhao","year":"2012","journal-title":"J Biol Chem."},{"issue":"9","key":"2022011306531787300_CIT0104","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1210\/ME.2015-1127","article-title":"Research resource: correlating human cytochrome P450 21A2 crystal structure and phenotypes of mutations in congenital adrenal hyperplasia","volume":"29","author":"Pallan","year":"2015","journal-title":"Mol Endocrinol."},{"issue":"19","key":"2022011306531787300_CIT0105","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1021\/bi102078e","article-title":"Why human cytochrome P450c21 is a progesterone 21-hydroxylase","volume":"50","author":"Mizrachi","year":"2011","journal-title":"Biochemistry."},{"issue":"6","key":"2022011306531787300_CIT0106","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1210\/mend-4-6-893","article-title":"Expression of human 21-hydroxylase (P450c21) in bacterial and mammalian cells: a system to characterize normal and mutant enzymes","volume":"4","author":"Hu","year":"1990","journal-title":"Mol Endocrinol."},{"issue":"5","key":"2022011306531787300_CIT0107","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1210\/mend-5-5-685","article-title":"A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele","volume":"5","author":"Tusie-Luna","year":"1991","journal-title":"Mol Endocrinol."},{"issue":"34","key":"2022011306531787300_CIT0108","doi-asserted-by":"crossref","first-page":"20916","DOI":"10.1016\/S0021-9258(17)45304-X","article-title":"Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus","volume":"265","author":"Tusie-Luna","year":"1990","journal-title":"J Biol Chem."},{"issue":"2","key":"2022011306531787300_CIT0109","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1172\/JCI115334","article-title":"Mutations of P450c21 (steroid 21-hydroxylase) at Cys428, Val281, and Ser268 result in complete, partial, or no loss of enzymatic activity, respectively","volume":"88","author":"Wu","year":"1991","journal-title":"J Clin Invest."},{"issue":"26","key":"2022011306531787300_CIT0110","doi-asserted-by":"crossref","first-page":"10767","DOI":"10.1074\/jbc.M117.792465","article-title":"Functional analysis of human cytochrome P450 21A2 variants involved in congenital adrenal hyperplasia","volume":"292","author":"Wang","year":"2017","journal-title":"J Biol Chem."},{"key":"2022011306531787300_CIT0111","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jsbmb.2018.03.003","article-title":"Catalytic modulation of human cytochromes P450 17A1 and P450 11B2 by phospholipid","volume":"181","author":"Peng","year":"2018","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"9","key":"2022011306531787300_CIT0112","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.tem.2004.09.004","article-title":"The backdoor pathway to dihydrotestosterone","volume":"15","author":"Auchus","year":"2004","journal-title":"Trends Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0113","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1210\/en.2002-220721","article-title":"5alpha-androstane-3alpha,17beta-diol is formed in tammar wallaby pouch young testes by a pathway involving 5alpha-pregnane-3alpha,17alpha-diol-20-one as a key intermediate","volume":"144","author":"Wilson","year":"2003","journal-title":"Endocrinology."},{"issue":"5","key":"2022011306531787300_CIT0114","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1210\/en.2005-1251","article-title":"Role of the alternate pathway of dihydrotestosterone formation in virilization of the Wolffian ducts of the tammar wallaby, Macropus eugenii","volume":"147","author":"Shaw","year":"2006","journal-title":"Endocrinology."},{"issue":"6","key":"2022011306531787300_CIT0115","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1071\/RD05034","article-title":"Ontogeny and pathway of formation of 5alpha-androstane-3alpha,17beta-diol in the testes of the immature brushtail possum Trichosurus vulpecula","volume":"17","author":"Wilson","year":"2005","journal-title":"Reprod Fertil Dev."},{"issue":"5","key":"2022011306531787300_CIT0116","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1071\/RD08253","article-title":"Formation of 5alpha-reduced androgens in the testes and urogenital tract of the grey short-tailed opossum, Monodelphis domestica","volume":"21","author":"Wilson","year":"2009","journal-title":"Reprod Fertil Dev."},{"issue":"2","key":"2022011306531787300_CIT0117","doi-asserted-by":"crossref","first-page":"e3000002","DOI":"10.1371\/journal.pbio.3000002","article-title":"Alternative (backdoor) androgen production and masculinization in the human fetus","volume":"17","author":"O\u2019Shaughnessy","year":"2019","journal-title":"PLoS Biol."},{"issue":"2","key":"2022011306531787300_CIT0118","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1210\/me.2005-0287","article-title":"Identification of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alpha-androstane-3alpha,17beta-diol to 5alpha-dihydrotestosterone: a potential therapeutic target for androgen-dependent disease","volume":"20","author":"Bauman","year":"2006","journal-title":"Mol Endocrinol."},{"issue":"3","key":"2022011306531787300_CIT0119","doi-asserted-by":"crossref","first-page":"E367","DOI":"10.1210\/jc.2011-1997","article-title":"Increased activation of the alternative \u201cbackdoor\u201d pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis","volume":"97","author":"Kamrath","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"2022011306531787300_CIT0120","doi-asserted-by":"crossref","first-page":"105439","DOI":"10.1016\/j.jsbmb.2019.105439","article-title":"Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review","volume":"194","author":"Schiffer","year":"2019","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"3","key":"2022011306531787300_CIT0121","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1210\/jc.2012-2912","article-title":"Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation","volume":"98","author":"Rege","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022011306531787300_CIT0122","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/EJE-15-1181","article-title":"Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency","volume":"174","author":"Turcu","year":"2016","journal-title":"Eur J Endocrinol."},{"key":"2022011306531787300_CIT0123","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mce.2014.12.009","article-title":"11\u03b2-Hydroxyandrostenedione: downstream metabolism by 11\u03b2HSD, 17\u03b2HSD and SRD5A produces novel substrates in familiar pathways","volume":"408","author":"Swart","year":"2015","journal-title":"Mol Cell Endocrinol."},{"key":"2022011306531787300_CIT0124","first-page":"219","article-title":"Androgens in teleost fishes","volume":"109C","author":"Borg","year":"1994","journal-title":"Comp Biochem Physiol."},{"issue":"12","key":"2022011306531787300_CIT0125","first-page":"4589","article-title":"11-Ketotestosterone is the dominant circulating bioactive androgen during normal and premature adrenarche","volume":"103","author":"Rege","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"key":"2022011306531787300_CIT0126","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jsbmb.2018.06.013","article-title":"11-Oxygenated androgen precursors are the preferred substrates for aldo-keto reductase 1C3 (AKR1C3): implications for castration resistant prostate cancer","volume":"183","author":"Barnard","year":"2018","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"3","key":"2022011306531787300_CIT0127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/endocr\/bqaa231","article-title":"11-Oxygenated estrogens are a novel class of human estrogens but do not contribute to the circulating estrogen pool","volume":"162","author":"Barnard","year":"2021","journal-title":"Endocrinology."},{"issue":"8","key":"2022011306531787300_CIT0128","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1210\/jc.2016-3989","article-title":"11-Oxygenated androgens are biomarkers of adrenal volume and testicular adrenal rest tumors in 21-hydroxylase deficiency","volume":"102","author":"Turcu","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2022011306531787300_CIT0129","doi-asserted-by":"crossref","first-page":"e2921","DOI":"10.1210\/clinem\/dgaa343","article-title":"Sex differences in 11-oxygenated androgen patterns across adulthood","volume":"105","author":"Davio","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022011306531787300_CIT0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1530\/EJE-20-0129","article-title":"Androgen excess and diagnostic steroid biomarkers for nonclassic 21-hydroxylase deficiency without cosyntropin stimulation","volume":"183","author":"Turcu","year":"2020","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2022011306531787300_CIT0131","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1210\/er.2018-00262","article-title":"Steroid metabolome analysis in disorders of adrenal steroid biosynthesis and metabolism","volume":"40","author":"Storbeck","year":"2019","journal-title":"Endocr Rev."},{"issue":"6","key":"2022011306531787300_CIT0132","first-page":"1797","article-title":"Modified-release and conventional glucocorticoids and diurnal androgen excretion in congenital adrenal hyperplasia","volume":"102","author":"Jones","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2022011306531787300_CIT0133","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0134","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s12020-015-0731-6","article-title":"Biochemical and genetic diagnosis of 21-hydroxylase deficiency","volume":"50","author":"Falhammar","year":"2015","journal-title":"Endocrine."},{"issue":"6","key":"2022011306531787300_CIT0135","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000501396","article-title":"Congenital adrenal hyperplasia: time to replace 17OHP with 21-deoxycortisol","volume":"91","author":"Miller","year":"2019","journal-title":"Horm Res Paediatr."},{"issue":"11","key":"2022011306531787300_CIT0136","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.1210\/jc.2019-00547","article-title":"Glucocorticoid activity of adrenal steroid precursors in untreated patients with congenital adrenal hyperplasia","volume":"104","author":"Engels","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2022011306531787300_CIT0137","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1210\/en.2015-1087","article-title":"Adrenal steroid metabolites accumulating in congenital adrenal hyperplasia lead to transactivation of the glucocorticoid receptor","volume":"156","author":"Pijnenburg-Kleizen","year":"2015","journal-title":"Endocrinology."},{"issue":"6","key":"2022011306531787300_CIT0138","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1530\/eje.0.1460789","article-title":"Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor","volume":"146","author":"Quinkler","year":"2002","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2022011306531787300_CIT0139","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1159\/000374112","article-title":"Influence of 17-hydroxyprogesterone, progesterone and sex steroids on mineralocorticoid receptor transactivation in congenital adrenal hyperplasia","volume":"83","author":"Mooij","year":"2015","journal-title":"Horm Res Paediatr."},{"issue":"3","key":"2022011306531787300_CIT0140","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/cen.13108","article-title":"A delayed diagnosis of salt-wasting congenital adrenal hyperplasia","volume":"85","author":"Pijnenburg-Kleizen","year":"2016","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"17","key":"2022011306531787300_CIT0141","doi-asserted-by":"crossref","first-page":"12919","DOI":"10.1016\/S0021-9258(18)31473-X","article-title":"Abundant adrenal-specific transcription of the human P450c21A \u201cpseudogene\u201d","volume":"268","author":"Bristow","year":"1993","journal-title":"J Biol Chem."},{"issue":"11","key":"2022011306531787300_CIT0142","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/hmg\/4.11.2109","article-title":"A promoter within intron 35 of the human C4A gene initiates abundant adrenal-specific transcription of a 1 kb RNA: location of a cryptic CYP21 promoter element?","volume":"4","author":"Tee","year":"1995","journal-title":"Hum Mol Genet."},{"issue":"14","key":"2022011306531787300_CIT0143","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1073\/pnas.83.14.5111","article-title":"Structure of human steroid 21-hydroxylase genes","volume":"83","author":"White","year":"1986","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"9","key":"2022011306531787300_CIT0144","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1073\/pnas.83.9.2841","article-title":"Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene","volume":"83","author":"Higashi","year":"1986","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"4","key":"2022011306531787300_CIT0145","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1073\/pnas.82.4.1089","article-title":"Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man","volume":"82","author":"White","year":"1985","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"2022011306531787300_CIT0146","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1083\/jcb.122.1.265","article-title":"Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B","volume":"122","author":"Bristow","year":"1993","journal-title":"J Cell Biol."},{"issue":"12","key":"2022011306531787300_CIT0147","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1084\/jem.191.12.2183","article-title":"Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in Caucasians. The load of RCCX genetic diversity on major histocompatibility complex-associated disease","volume":"191","author":"Blanchong","year":"2000","journal-title":"J Exp Med."},{"issue":"17","key":"2022011306531787300_CIT0148","doi-asserted-by":"crossref","first-page":"12147","DOI":"10.1074\/jbc.274.17.12147","article-title":"Modular variations of the human major histocompatibility complex class III genes for serine\/threonine kinase RP, complement component C4, steroid 21-hydroxylase CYP21, and tenascin TNX (the RCCX module). A mechanism for gene deletions and disease associations","volume":"274","author":"Yang","year":"1999","journal-title":"J Biol Chem."},{"issue":"12","key":"2022011306531787300_CIT0149","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00439-012-1217-8","article-title":"Complement component 4 copy number variation and CYP21A2 genotype associations in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"131","author":"Chen","year":"2012","journal-title":"Hum Genet."},{"issue":"1","key":"2022011306531787300_CIT0150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1172\/JCI113562","article-title":"Nonsense mutation causing steroid 21-hydroxylase deficiency","volume":"82","author":"Globerman","year":"1988","journal-title":"J Clin Invest."},{"issue":"20","key":"2022011306531787300_CIT0151","doi-asserted-by":"crossref","first-page":"7486","DOI":"10.1073\/pnas.85.20.7486","article-title":"Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: possible gene conversion products","volume":"85","author":"Higashi","year":"1988","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"2022011306531787300_CIT0152","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1073\/pnas.85.5.1600","article-title":"Mutation in the CYP21B gene (Ile-172----Asn) causes steroid 21-hydroxylase deficiency","volume":"85","author":"Amor","year":"1988","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"2022011306531787300_CIT0153","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1056\/NEJM198807073190104","article-title":"Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14,DR1","volume":"319","author":"Speiser","year":"1988","journal-title":"N Engl J Med."},{"issue":"4","key":"2022011306531787300_CIT0154","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1172\/JCI25091","article-title":"In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development","volume":"116","author":"Goto","year":"2006","journal-title":"J Clin Invest."},{"issue":"1-2","key":"2022011306531787300_CIT0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0303-7207(00)00445-7","article-title":"Temporal and spatial distribution of corticosteroidogenic enzymes immunoreactivity in developing human adrenal","volume":"174","author":"Narasaka","year":"2001","journal-title":"Mol Cell Endocrinol."},{"issue":"4","key":"2022011306531787300_CIT0156","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1172\/JCI28296","article-title":"Ontogeny of adrenal steroid biosynthesis: why girls will be girls","volume":"116","author":"White","year":"2006","journal-title":"J Clin Invest."},{"issue":"3","key":"2022011306531787300_CIT0157","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0378-3782(97)00037-6","article-title":"Immature adrenal steroidogenesis in preterm infants","volume":"49","author":"Nomura","year":"1997","journal-title":"Early Hum Dev."},{"issue":"2","key":"2022011306531787300_CIT0158","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0046-8177(88)80346-0","article-title":"Immunohistochemical localization of cytochrome P-450C21 in human adrenal cortex and its relation to endocrine function","volume":"19","author":"Sasano","year":"1988","journal-title":"Hum Pathol."},{"issue":"1","key":"2022011306531787300_CIT0159","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0303-7207(96)03997-4","article-title":"Steroid 21-hydroxylase expression and activity in human lymphocytes","volume":"127","author":"Zhou","year":"1997","journal-title":"Mol Cell Endocrinol."},{"issue":"7","key":"2022011306531787300_CIT0160","first-page":"2519","article-title":"Steroidogenic enzyme gene expression in the human heart","volume":"85","author":"Kayes-Wandover","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022011306531787300_CIT0161","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/jc.2004-0865","article-title":"Corticotropin-releasing hormone directly stimulates cortisol and the cortisol biosynthetic pathway in human fetal adrenal cells","volume":"90","author":"Sirianni","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"issue":"20","key":"2022011306531787300_CIT0162","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM199505183322008","article-title":"The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation","volume":"332","author":"Chrousos","year":"1995","journal-title":"N Engl J Med."},{"issue":"5","key":"2022011306531787300_CIT0163","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1210\/endo.138.5.5239","article-title":"Interleukin-3 and interleukin-6 stimulate cortisol secretion from adult human adrenocortical cells","volume":"138","author":"Weber","year":"1997","journal-title":"Endocrinology."},{"issue":"5","key":"2022011306531787300_CIT0164","first-page":"1592","article-title":"Protein kinase A, protein kinase C, and Ca(2+)-regulated expression of 21-hydroxylase cytochrome P450 in H295R human adrenocortical cells","volume":"83","author":"Bird","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0165","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/me.2003-0005","article-title":"The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production","volume":"18","author":"Bassett","year":"2004","journal-title":"Mol Endocrinol."},{"issue":"3-4","key":"2022011306531787300_CIT0166","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/07435809809032614","article-title":"Battle of the kinases: integration of adrenal responses to cAMP, DG and Ca2+ at the level of steroidogenic cytochromes P450 and 3betaHSD expression in H295R cells","volume":"24","author":"Bird","year":"1998","journal-title":"Endocr Res."},{"issue":"2","key":"2022011306531787300_CIT0167","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1677\/joe.0.1810355","article-title":"Modulation of steroidogenic enzymes by orphan nuclear transcriptional regulation may control diverse production of cortisol and androgens in the human adrenal","volume":"181","author":"Kelly","year":"2004","journal-title":"J Endocrinol."},{"issue":"1","key":"2022011306531787300_CIT0168","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0303-7207(97)00224-4","article-title":"CYP21 pseudogene transcripts are much less abundant than those from the active gene in normal human adrenocortical cells under various conditions in culture","volume":"137","author":"Endoh","year":"1998","journal-title":"Mol Cell Endocrinol."},{"issue":"5","key":"2022011306531787300_CIT0169","doi-asserted-by":"crossref","first-page":"R1601","DOI":"10.1152\/ajpregu.91034.2008","article-title":"Hypocretin\/orexin increases the expression of steroidogenic enzymes in human adrenocortical NCI H295R cells","volume":"297","author":"Wenzel","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"issue":"4","key":"2022011306531787300_CIT0170","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1897\/06-388R1.1","article-title":"Effects of brominated flame retardants and brominated dioxins on steroidogenesis in H295R human adrenocortical carcinoma cell line","volume":"26","author":"Ding","year":"2007","journal-title":"Environ Toxicol Chem."},{"issue":"10","key":"2022011306531787300_CIT0171","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.chemosphere.2008.01.032","article-title":"Effects of fifteen PBDE metabolites, DE71, DE79 and TBBPA on steroidogenesis in the H295R cell line","volume":"71","author":"Song","year":"2008","journal-title":"Chemosphere."},{"issue":"6","key":"2022011306531787300_CIT0172","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.envint.2006.03.011","article-title":"Alteration of steroidogenesis in H295R cells by organic sediment contaminants and relationships to other endocrine disrupting effects","volume":"32","author":"Bl\u00e1ha","year":"2006","journal-title":"Environ Int."},{"issue":"11","key":"2022011306531787300_CIT0173","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/hmg\/5.11.1749","article-title":"Alternate promoters and alternate splicing of human tenascin-X, a gene with 5\u2019 and 3\u2019 ends buried in other genes","volume":"5","author":"Speek","year":"1996","journal-title":"Hum Mol Genet."},{"issue":"10","key":"2022011306531787300_CIT0174","first-page":"1330","article-title":"Difference in transcriptional activity of two homologous CYP21A genes","volume":"9","author":"Chang","year":"1995","journal-title":"Mol Endocrinol."},{"issue":"4","key":"2022011306531787300_CIT0175","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/07435809509030491","article-title":"Constitutive human steroid 21-hydroxylase promoter gene and pseudogene activity in steroidogenic and nonsteroidogenic cells with the luciferase gene as a reporter","volume":"21","author":"Kyllo","year":"1995","journal-title":"Endocr Res."},{"issue":"8","key":"2022011306531787300_CIT0176","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/nar\/26.8.1959","article-title":"The -104G nucleotide of the human CYP21 gene is important for CYP21 transcription activity and protein interaction","volume":"26","author":"Chin","year":"1998","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"2022011306531787300_CIT0177","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1210\/jc.2006-2163","article-title":"Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency","volume":"92","author":"Ara\u00fajo","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0178","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2265.2005.02184.x","article-title":"Substitutions in the CYP21A2 promoter explain the simple-virilizing form of 21-hydroxylase deficiency in patients harbouring a P30L mutation","volume":"62","author":"Araujo","year":"2005","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"3","key":"2022011306531787300_CIT0179","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1210\/edrv.18.3.0301","article-title":"Steroidogenic factor 1: a key determinant of endocrine development and function","volume":"18","author":"Parker","year":"1997","journal-title":"Endocr Rev."},{"issue":"7","key":"2022011306531787300_CIT0180","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1210\/me.2009-0519","article-title":"Minireview: steroidogenic factor 1: its roles in differentiation, development, and disease","volume":"24","author":"Schimmer","year":"2010","journal-title":"Mol Endocrinol."},{"issue":"53","key":"2022011306531787300_CIT0181","doi-asserted-by":"crossref","first-page":"38097","DOI":"10.1074\/jbc.274.53.38097","article-title":"Transcriptional regulatory elements of the human gene for cytochrome P450c21 (steroid 21-hydroxylase) lie within intron 35 of the linked C4B gene","volume":"274","author":"Wijesuriya","year":"1999","journal-title":"J Biol Chem."},{"issue":"2","key":"2022011306531787300_CIT0182","first-page":"861","article-title":"The orphan nuclear receptor NGFI-B regulates expression of the gene encoding steroid 21-hydroxylase","volume":"13","author":"Wilson","year":"1993","journal-title":"Mol Cell Biol."},{"issue":"8","key":"2022011306531787300_CIT0183","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1128\/MCB.15.8.4331","article-title":"Adrenocortical function and regulation of the steroid 21-hydroxylase gene in NGFI-B-deficient mice","volume":"15","author":"Crawford","year":"1995","journal-title":"Mol Cell Biol."},{"issue":"7","key":"2022011306531787300_CIT0184","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1210\/endo.141.7.7562","article-title":"Nuclear receptors Nor1 and NGFI-B\/Nur77 play similar, albeit distinct, roles in the hypothalamo-pituitary-adrenal axis","volume":"141","author":"Fernandez","year":"2000","journal-title":"Endocrinology."},{"issue":"23","key":"2022011306531787300_CIT0185","doi-asserted-by":"crossref","first-page":"10796","DOI":"10.1073\/pnas.92.23.10796","article-title":"Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms","volume":"92","author":"Tusi\u00e9-Luna","year":"1995","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"12","key":"2022011306531787300_CIT0186","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1210\/jcem.85.12.7018","article-title":"How a patient homozygous for a 30-kb deletion of the C4-CYP 21 genomic region can have a nonclassic form of 21-hydroxylase deficiency","volume":"85","author":"L\u2019Allemand","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022011306531787300_CIT0187","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ymgme.2007.10.008","article-title":"Low frequency of the CYP21A2 deletion in ethnic Chinese (Taiwanese) patients with 21-hydroxylase deficiency","volume":"93","author":"Lee","year":"2008","journal-title":"Mol Genet Metab."},{"issue":"1","key":"2022011306531787300_CIT0188","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ng0997-104","article-title":"Tenascin-X deficiency is associated with Ehlers-Danlos syndrome","volume":"17","author":"Burch","year":"1997","journal-title":"Nat Genet."},{"issue":"2","key":"2022011306531787300_CIT0189","doi-asserted-by":"crossref","first-page":"E379","DOI":"10.1210\/jc.2012-3148","article-title":"Tenascin-X haploinsufficiency associated with Ehlers-Danlos syndrome in patients with congenital adrenal hyperplasia","volume":"98","author":"Merke","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2022011306531787300_CIT0190","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1210\/clinem\/dgaa199","article-title":"The prevalence of the chimeric TNXA\/TNXB gene and clinical symptoms of Ehlers-Danlos Syndrome with 21-hydroxylase deficiency","volume":"105","author":"Gao","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2022011306531787300_CIT0191","doi-asserted-by":"crossref","first-page":"E1143","DOI":"10.1210\/jc.2015-2232","article-title":"Broadening the spectrum of Ehlers Danlos syndrome in patients with congenital adrenal hyperplasia","volume":"100","author":"Morissette","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022011306531787300_CIT0192","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000481911","article-title":"Tenascin-X, congenital adrenal hyperplasia, and the CAH-X syndrome","volume":"89","author":"Miller","year":"2018","journal-title":"Horm Res Paediatr."},{"issue":"2","key":"2022011306531787300_CIT0193","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1172\/JCI115897","article-title":"Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"90","author":"Speiser","year":"1992","journal-title":"J Clin Invest."},{"issue":"5","key":"2022011306531787300_CIT0194","first-page":"1145","article-title":"Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation","volume":"78","author":"Wedell","year":"1994","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0195","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/humu.1380050205","article-title":"Screening of CYP21 gene mutations in 129 French patients affected by steroid 21-hydroxylase deficiency","volume":"5","author":"Barbat","year":"1995","journal-title":"Hum Mutat."},{"issue":"6","key":"2022011306531787300_CIT0196","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s004390050280","article-title":"Point mutations in Italian patients with classic, non-classic, and cryptic forms of steroid 21-hydroxylase deficiency","volume":"98","author":"Carrera","year":"1996","journal-title":"Hum Genet."},{"issue":"10","key":"2022011306531787300_CIT0197","first-page":"3293","article-title":"Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population","volume":"82","author":"J\u00e4\u00e4skel\u00e4inen","year":"1997","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2022011306531787300_CIT0198","first-page":"4416","article-title":"Molecular genotyping in Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency","volume":"83","author":"Bachega","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0199","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1210\/jcem.85.3.6441","article-title":"Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany","volume":"85","author":"Krone","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2022011306531787300_CIT0200","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1210\/jcem.86.10.7898","article-title":"Mutational spectrum of the steroid 21-hydroxylase gene in Austria: identification of a novel missense mutation","volume":"86","author":"Baumgartner-Parzer","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2022011306531787300_CIT0201","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1210\/jc.2002-021681","article-title":"CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations","volume":"88","author":"Stikkelbroeck","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0202","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2265.2006.02465.x","article-title":"High variability in CYP21A2 mutated alleles in Spanish 21-hydroxylase deficiency patients, six novel mutations and a founder effect","volume":"64","author":"Loidi","year":"2006","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"1","key":"2022011306531787300_CIT0203","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ymgme.2005.11.015","article-title":"CYP21A2 mutations in Portuguese patients with congenital adrenal hyperplasia: identification of two novel mutations and characterization of four different partial gene conversions","volume":"88","author":"Fri\u00e3es","year":"2006","journal-title":"Mol Genet Metab."},{"issue":"4","key":"2022011306531787300_CIT0204","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ymgme.2006.12.005","article-title":"Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency","volume":"90","author":"Wilson","year":"2007","journal-title":"Mol Genet Metab."},{"issue":"3","key":"2022011306531787300_CIT0205","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4008\/jcrpe.v1i3.49","article-title":"CYP21A2 gene mutations in congenital adrenal hyperplasia: genotype-phenotype correlation in Turkish children","volume":"1","author":"Ba\u015f","year":"2009","journal-title":"J Clin Res Pediatr Endocrinol."},{"issue":"1","key":"2022011306531787300_CIT0206","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.1210\/jc.2010-0319","article-title":"Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"96","author":"Finkielstain","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022011306531787300_CIT0207","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1530\/EJE-12-0196","article-title":"Genetic, anthropometric and metabolic features of adult Norwegian patients with 21-hydroxylase deficiency","volume":"167","author":"Nermoen","year":"2012","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2022011306531787300_CIT0208","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1089\/gtmb.2011.0099","article-title":"Mutation analysis of the CYP21A2 gene in the Iranian population","volume":"16","author":"Rabbani","year":"2012","journal-title":"Genet Test Mol Biomarkers."},{"issue":"1","key":"2022011306531787300_CIT0209","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.gene.2012.07.027","article-title":"Steroid 21-hydroxylase gene mutational spectrum in 50 Tunisian patients: characterization of three novel polymorphisms","volume":"507","author":"Ben Charfeddine","year":"2012","journal-title":"Gene."},{"issue":"2","key":"2022011306531787300_CIT0210","doi-asserted-by":"crossref","first-page":"E346","DOI":"10.1210\/jc.2012-3343","article-title":"Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort","volume":"98","author":"Krone","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2022011306531787300_CIT0211","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1073\/pnas.1300057110","article-title":"Genotype-phenotype correlation in 1507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency","volume":"110","author":"New","year":"2013","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"2022011306531787300_CIT0212","doi-asserted-by":"crossref","first-page":"e2138","DOI":"10.1371\/journal.pone.0002138","article-title":"High frequency of copy number variations and sequence variants at CYP21A2 locus: implication for the genetic diagnosis of 21-hydroxylase deficiency","volume":"3","author":"Parajes","year":"2008","journal-title":"PLoS One."},{"issue":"10","key":"2022011306531787300_CIT0213","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2009-0487","article-title":"Duplications of the functional CYP21A2 gene are primarily restricted to Q318X alleles: evidence for a founder effect","volume":"94","author":"Kleinle","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022011306531787300_CIT0214","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1002\/mgg3.671","article-title":"Genotype-phenotype correlation study and mutational and hormonal analysis in a Chinese cohort with 21-hydroxylase deficiency","volume":"7","author":"Xu","year":"2019","journal-title":"Mol Genet Genomic Med."},{"issue":"12","key":"2022011306531787300_CIT0215","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1210\/jc.2012-2102","article-title":"Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia","volume":"97","author":"Finkielstain","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022011306531787300_CIT0216","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2265.2011.04123.x","article-title":"Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype-phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia","volume":"75","author":"Marino","year":"2011","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"2","key":"2022011306531787300_CIT0217","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1651-2227.1998.tb00968.x","article-title":"Molecular genetics of congenital adrenal hyperplasia (21-hydroxylase deficiency): implications for diagnosis, prognosis and treatment","volume":"87","author":"Wedell","year":"1998","journal-title":"Acta Paediatr."},{"key":"2022011306531787300_CIT0218","doi-asserted-by":"crossref","first-page":"108474","DOI":"10.1016\/j.steroids.2019.108474","article-title":"Analysis of phenotypes and genotypes in 84 patients with 21-Hydroxylase deficiency in southern China","volume":"151","author":"Hou","year":"2019","journal-title":"Steroids."},{"issue":"6","key":"2022011306531787300_CIT0219","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/S0021-9258(19)39804-7","article-title":"A missense mutation at Ile 172----Asn or Arg356----Trp causes steroid 21-hydroxylase deficiency","volume":"265","author":"Chiou","year":"1990","journal-title":"J Biol Chem."},{"issue":"2","key":"2022011306531787300_CIT0220","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12020-020-02323-3","article-title":"Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"69","author":"Kocova","year":"2020","journal-title":"Endocrine."},{"issue":"1","key":"2022011306531787300_CIT0221","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/nyas.13370","article-title":"Linking the degree of virilization in females with congenital adrenal hyperplasia to genotype","volume":"1402","author":"Gurgov","year":"2017","journal-title":"Ann N Y Acad Sci."},{"issue":"4","key":"2022011306531787300_CIT0222","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/MOP.0b013e32834810a4","article-title":"Adult women with 21-hydroxylase deficient congenital adrenal hyperplasia, surgical and psychological aspects","volume":"23","author":"Nordenstr\u00f6m","year":"2011","journal-title":"Curr Opin Pediatr."},{"issue":"1","key":"2022011306531787300_CIT0223","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1210\/jc.2003-030696","article-title":"Behavioral and physical masculinization are related to genotype in girls with congenital adrenal hyperplasia","volume":"89","author":"Hall","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2022011306531787300_CIT0224","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1210\/jc.2003-030123","article-title":"CYP21 genotype, adult height, and pubertal development in 55 patients treated for 21-hydroxylase deficiency","volume":"88","author":"Balsamo","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022011306531787300_CIT0225","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10508-007-9265-1","article-title":"Sexual orientation in women with classical or non-classical congenital adrenal hyperplasia as a function of degree of prenatal androgen excess","volume":"37","author":"Meyer-Bahlburg","year":"2008","journal-title":"Arch Sex Behav."},{"issue":"4","key":"2022011306531787300_CIT0226","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1210\/jc.2013-3326","article-title":"Suboptimal psychosocial outcomes in patients with congenital adrenal hyperplasia: epidemiological studies in a nonbiased national cohort in Sweden","volume":"99","author":"Strandqvist","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"11-12","key":"2022011306531787300_CIT0227","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00439-018-1959-z","article-title":"Complement component 4 variations may influence psychopathology risk in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"137","author":"Lao","year":"2018","journal-title":"Hum Genet."},{"issue":"7","key":"2022011306531787300_CIT0228","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1073\/pnas.1221133110","article-title":"Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia","volume":"110","author":"Haider","year":"2013","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"3","key":"2022011306531787300_CIT0229","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/j.semperi.2015.03.002","article-title":"Current status of newborn screening worldwide: 2015","volume":"39","author":"Therrell","year":"2015","journal-title":"Semin Perinatol."},{"issue":"9","key":"2022011306531787300_CIT0230","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nrendo.2009.148","article-title":"Neonatal screening for congenital adrenal hyperplasia","volume":"5","author":"White","year":"2009","journal-title":"Nat Rev Endocrinol."},{"issue":"4","key":"2022011306531787300_CIT0231","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00008480-199708000-00018","article-title":"Current status of neonatal screening for congenital adrenal hyperplasia","volume":"9","author":"Pang","year":"1997","journal-title":"Curr Opin Pediatr."},{"issue":"1","key":"2022011306531787300_CIT0232","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0889-8529(08)70017-3","article-title":"Newborn screening for congenital adrenal hyperplasia","volume":"30","author":"Therrell","year":"2001","journal-title":"Endocrinol Metab Clin North Am."},{"key":"2022011306531787300_CIT0233","doi-asserted-by":"crossref","first-page":"U71","DOI":"10.1530\/eje.0.151u071","article-title":"Neonatal screening for congenital adrenal hyperplasia","volume":"151","author":"van der Kamp","year":"2004","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2022011306531787300_CIT0234","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/ijns6020037","article-title":"Newborn screening protocols and positive predictive value for congenital adrenal hyperplasia vary across the United States","volume":"6","author":"Speiser","year":"2020","journal-title":"Int J Neonatal Screen."},{"issue":"3 Pt 1","key":"2022011306531787300_CIT0235","first-page":"362","article-title":"Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995","volume":"98","author":"Balsamo","year":"1996","journal-title":"Pediatrics."},{"issue":"12","key":"2022011306531787300_CIT0236","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1001\/archpedi.153.12.1272","article-title":"Effect of newborn screening for congenital adrenal hyperplasia","volume":"153","author":"Brosnan","year":"1999","journal-title":"Arch Pediatr Adolesc Med."},{"issue":"4","key":"2022011306531787300_CIT0237","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1542\/peds.101.4.e11","article-title":"Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden","volume":"101","author":"Thil\u2019en","year":"1998","journal-title":"Pediatrics."},{"issue":"1","key":"2022011306531787300_CIT0238","first-page":"22","article-title":"Female preponderance in congenital adrenal hyperplasia due to CYP21 deficiency in England: implications for neonatal screening","volume":"63","author":"Nordenstr\u00f6m","year":"2005","journal-title":"Horm Res."},{"issue":"2","key":"2022011306531787300_CIT0239","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jfma.2017.03.008","article-title":"Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening","volume":"117","author":"Liu","year":"2018","journal-title":"J Formos Med Assoc."},{"issue":"2","key":"2022011306531787300_CIT0240","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/archdischild-2013-304473","article-title":"No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening","volume":"99","author":"Hird","year":"2014","journal-title":"Arch Dis Child."},{"issue":"2","key":"2022011306531787300_CIT0241","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1530\/EC-18-0281","article-title":"Genotype\/phenotype correlations in 538 congenital adrenal hyperplasia patients from Germany and Austria: discordances in milder genotypes and in screened versus prescreening patients","volume":"8","author":"Riedl","year":"2019","journal-title":"Endocr Connect."},{"issue":"6","key":"2022011306531787300_CIT0242","first-page":"284","article-title":"How many deaths can be prevented by newborn screening for congenital adrenal hyperplasia?","volume":"67","author":"Grosse","year":"2007","journal-title":"Horm Res."},{"issue":"1","key":"2022011306531787300_CIT0243","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12902-018-0263-1","article-title":"Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany","volume":"18","author":"D\u00f6rr","year":"2018","journal-title":"BMC Endocr Disord."},{"issue":"6","key":"2022011306531787300_CIT0244","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1542\/peds.108.6.1320","article-title":"Newborn screening for congenital adrenal hyperplasia in the Netherlands","volume":"108","author":"Van der Kamp","year":"2001","journal-title":"Pediatrics."},{"key":"2022011306531787300_CIT0245","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpeds.2019.12.057","article-title":"Clinical impact and cost efficacy of newborn screening for congenital adrenal hyperplasia","volume":"220","author":"Fox","year":"2020","journal-title":"J Pediatr."},{"issue":"5 Pt 2","key":"2022011306531787300_CIT0246","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1542\/peds.2005-2633H","article-title":"Comprehensive cost-utility analysis of newborn screening strategies","volume":"117","author":"Carroll","year":"2006","journal-title":"Pediatrics."},{"issue":"1","key":"2022011306531787300_CIT0247","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jpeds.2013.01.002","article-title":"Congenital adrenal hyperplasia and the second newborn screen","volume":"163","author":"Chan","year":"2013","journal-title":"J Pediatr."},{"issue":"5","key":"2022011306531787300_CIT0248","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/jcem-45-5-1003","article-title":"Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia","volume":"45","author":"Pang","year":"1977","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2022011306531787300_CIT0249","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/clinchem\/36.9.1667","article-title":"Direct solid-phase time-resolved fluoroimmunoassay of 17 alpha-hydroxyprogesterone in serum and dried blood spots on filter paper","volume":"36","author":"Gonzalez","year":"1990","journal-title":"Clin Chem."},{"issue":"6","key":"2022011306531787300_CIT0250","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/jamapediatrics.2013.5321","article-title":"Nationwide neonatal screening for congenital adrenal hyperplasia in Sweden: a 26-year longitudinal prospective population-based study","volume":"168","author":"Gidl\u00f6f","year":"2014","journal-title":"JAMA Pediatr."},{"issue":"12","key":"2022011306531787300_CIT0251","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1210\/jc.2002-021732","article-title":"Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value","volume":"88","author":"Olgem\u00f6ller","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022011306531787300_CIT0252","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jpeds.2014.01.038","article-title":"Comparison of newborn screening protocols for congenital adrenal hyperplasia in preterm infants","volume":"164","author":"Sarafoglou","year":"2014","journal-title":"J Pediatr."},{"issue":"11","key":"2022011306531787300_CIT0253","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1515\/jpem-2019-0140","article-title":"The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling","volume":"32","author":"Jiang","year":"2019","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"4","key":"2022011306531787300_CIT0254","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/cen.13292","article-title":"Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening","volume":"86","author":"Hayashi","year":"2017","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"3","key":"2022011306531787300_CIT0255","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ymgme.2015.08.004","article-title":"Congenital adrenal hyperplasia cases identified by newborn screening in one- and two-screen states","volume":"116","author":"Held","year":"2015","journal-title":"Mol Genet Metab."},{"issue":"5","key":"2022011306531787300_CIT0256","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1203\/01.PDR.0000142733.50918.6E","article-title":"Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia","volume":"56","author":"Gatelais","year":"2004","journal-title":"Pediatr Res."},{"issue":"9","key":"2022011306531787300_CIT0257","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1001\/archpedi.155.9.1038","article-title":"Antenatal corticosteroids and newborn screening for congenital adrenal hyperplasia","volume":"155","author":"King","year":"2001","journal-title":"Arch Pediatr Adolesc Med."},{"issue":"4","key":"2022011306531787300_CIT0258","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jpeds.2005.04.035","article-title":"Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls","volume":"147","author":"Varness","year":"2005","journal-title":"J Pediatr."},{"issue":"7","key":"2022011306531787300_CIT0259","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/archdischild-2018-315972","article-title":"Evaluation of the Dutch neonatal screening for congenital adrenal hyperplasia","volume":"104","author":"van der Linde","year":"2019","journal-title":"Arch Dis Child."},{"issue":"22","key":"2022011306531787300_CIT0260","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1001\/jama.2012.5281","article-title":"Cases of congenital adrenal hyperplasia missed by newborn screening in Minnesota","volume":"307","author":"Sarafoglou","year":"2012","journal-title":"JAMA."},{"issue":"8","key":"2022011306531787300_CIT0261","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1210\/jc.2003-032235","article-title":"Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia","volume":"89","author":"Minutti","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022011306531787300_CIT0262","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.steroids.2006.01.015","article-title":"Automated, fast and sensitive quantification of 17 alpha-hydroxy-progesterone, androstenedione and testosterone by tandem mass spectrometry with on-line extraction","volume":"71","author":"Rauh","year":"2006","journal-title":"Steroids."},{"issue":"13","key":"2022011306531787300_CIT0263","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.steroids.2011.07.013","article-title":"Rapid steroid hormone quantification for congenital adrenal hyperplasia (CAH) in dried blood spots using UPLC liquid chromatography-tandem mass spectrometry","volume":"76","author":"Janzen","year":"2011","journal-title":"Steroids."},{"issue":"5","key":"2022011306531787300_CIT0264","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4155\/bio.16.6","article-title":"Determination of a steroid profile in heel prick blood using LC-MS\/MS","volume":"8","author":"Boelen","year":"2016","journal-title":"Bioanalysis."},{"issue":"12","key":"2022011306531787300_CIT0265","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1373\/clinchem.2017.271106","article-title":"High-resolution, accurate-mass (HRAM) mass spectrometry urine steroid profiling in the diagnosis of adrenal disorders","volume":"63","author":"Hines","year":"2017","journal-title":"Clin Chem."},{"key":"2022011306531787300_CIT0266","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jsbmb.2015.10.013","article-title":"Diagnosis of 21-hydroxylase deficiency by urinary metabolite ratios using gas chromatography-mass spectrometry analysis: reference values for neonates and infants","volume":"156","author":"Kamrath","year":"2016","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"4","key":"2022011306531787300_CIT0267","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10545-007-0691-y","article-title":"Reduction of the false-positive rate in newborn screening by implementation of MS\/MS-based second-tier tests: the Mayo Clinic experience (2004-2007)","volume":"30","author":"Matern","year":"2007","journal-title":"J Inherit Metab Dis."},{"issue":"3","key":"2022011306531787300_CIT0268","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/ijns6030063","article-title":"Evaluation of a two-tier screening pathway for congenital adrenal hyperplasia in the New South Wales newborn screening programme","volume":"6","author":"Lai","year":"2020","journal-title":"Int J Neonatal Screen."},{"issue":"3","key":"2022011306531787300_CIT0269","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/jp.2016.223","article-title":"Utility of a precursor-to-product ratio in the evaluation of presumptive positives in newborn screening of congenital adrenal hyperplasia","volume":"37","author":"Tieh","year":"2017","journal-title":"J Perinatol."},{"issue":"2","key":"2022011306531787300_CIT0270","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1203\/PDR.0b013e3181aa3777","article-title":"Use of steroid profiling by UPLC-MS\/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience","volume":"66","author":"Schwarz","year":"2009","journal-title":"Pediatr Res."},{"issue":"1","key":"2022011306531787300_CIT0271","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1515\/jpm-2013-0154","article-title":"Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation","volume":"42","author":"Seo","year":"2014","journal-title":"J Perinat Med."},{"key":"2022011306531787300_CIT0272","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa371","article-title":"Application of principal component analysis to newborn screening for congenital adrenal hyperplasia","author":"Lasarev","year":"2020;105(8):2930-2940","journal-title":"J Clin Endocrinol Metab."},{"issue":"21-22","key":"2022011306531787300_CIT0273","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.cca.2010.06.029","article-title":"Pilot proficiency testing study for second tier congenital adrenal hyperplasia newborn screening","volume":"411","author":"De Jes\u00fas","year":"2010","journal-title":"Clin Chim Acta."},{"issue":"5","key":"2022011306531787300_CIT0274","doi-asserted-by":"crossref","first-page":"e0233724","DOI":"10.1371\/journal.pone.0233724","article-title":"Storage stability of five steroids and in dried blood spots for newborn screening and retrospective diagnosis of congenital adrenal hyperplasia","volume":"15","author":"Grecs\u00f3","year":"2020","journal-title":"PLoS One."},{"issue":"3","key":"2022011306531787300_CIT0275","first-page":"960","article-title":"Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia","volume":"84","author":"Fitness","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0276","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1373\/clinchem.2004.042416","article-title":"Rapid second-tier molecular genetic analysis for congenital adrenal hyperplasia attributable to steroid 21-hydroxylase deficiency","volume":"51","author":"K\u00f6sel","year":"2005","journal-title":"Clin Chem."},{"key":"2022011306531787300_CIT0277","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cca.2012.09.013","article-title":"Reverse-hybridization assay for rapid detection of common CYP21A2 mutations in dried blood spots from newborns with elevated 17-OH progesterone","volume":"414","author":"N\u00e9meth","year":"2012","journal-title":"Clin Chim Acta."},{"issue":"5","key":"2022011306531787300_CIT0278","first-page":"1505","article-title":"Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency","volume":"84","author":"Nordenstr\u00f6m","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022011306531787300_CIT0279","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1399-0004.2009.01274.x","article-title":"Molecular analysis of CYP21A2 can optimize the follow-up of positive results in newborn screening for congenital adrenal hyperplasia","volume":"76","author":"Silveira","year":"2009","journal-title":"Clin Genet."},{"issue":"3","key":"2022011306531787300_CIT0280","first-page":"197","article-title":"Molecular analysis of the CYP21A2 gene in dried blood spot samples","volume":"80","author":"Marino","year":"2020","journal-title":"Medicina (B Aires)."},{"key":"2022011306531787300_CIT0281","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jsbmb.2017.09.003","article-title":"The art of measuring steroids: principles and practice of current hormonal steroid analysis","volume":"179","author":"Wudy","year":"2018","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"1","key":"2022011306531787300_CIT0282","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1203\/00006450-199507000-00013","article-title":"17 alpha-hydroxyprogesterone, 4-androstenedione, and testosterone profiled by routine stable isotope dilution\/gas chromatography-mass spectrometry in plasma of children","volume":"38","author":"Wudy","year":"1995","journal-title":"Pediatr Res."},{"issue":"9","key":"2022011306531787300_CIT0283","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/clinchem\/38.9.1830","article-title":"Identification of the steroids in neonatal plasma that interfere with 17 alpha-hydroxyprogesterone radioimmunoassays","volume":"38","author":"Wong","year":"1992","journal-title":"Clin Chem."},{"issue":"3","key":"2022011306531787300_CIT0284","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0378-3782(97)90554-5","article-title":"15 beta-hydroxylated steroids may be diagnostically misleading in confirming congenital adrenal hyperplasia suspected by a newborn screening programme","volume":"49","author":"Lange-Kubini","year":"1997","journal-title":"Early Hum Dev."},{"issue":"2","key":"2022011306531787300_CIT0285","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00216-018-1449-0","article-title":"Liquid chromatography-tandem mass spectrometry analysis of 17-hydroxyprogesterone in dried blood spots revealed matrix effect on immunoassay","volume":"411","author":"Han","year":"2019","journal-title":"Anal Bioanal Chem."},{"issue":"1","key":"2022011306531787300_CIT0286","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1542\/peds.97.1.100","article-title":"Screening for congenital adrenal hyperplasia: the Delfia Screening Test overestimates serum 17-hydroxyprogesterone in preterm infants","volume":"97","author":"al Saedi","year":"1996","journal-title":"Pediatrics."},{"key":"2022011306531787300_CIT0287","doi-asserted-by":"crossref","first-page":"105412","DOI":"10.1016\/j.jsbmb.2019.105412","article-title":"Characterizing the steroidal milieu in amniotic fluid of mid-gestation: a GC-MS study","volume":"193","author":"Wang","year":"2019","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"2","key":"2022011306531787300_CIT0288","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0002-9343(86)90262-7","article-title":"Familial male pseudohermaphroditism due to 5-alpha-reductase deficiency in a Turkish village","volume":"81","author":"Akgun","year":"1986","journal-title":"Am J Med."},{"issue":"3","key":"2022011306531787300_CIT0289","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1530\/REP-16-0434","article-title":"Reproductive performance primarily depends on the female genotype in a two-factorial breeding experiment using high-fertility mouse lines","volume":"153","author":"Langhammer","year":"2017","journal-title":"Reproduction."},{"issue":"4","key":"2022011306531787300_CIT0290","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1515\/cclm-2016-0394","article-title":"Harmonisation of serum dihydrotestosterone analysis: establishment of an external quality assurance program","volume":"55","author":"Greaves","year":"2017","journal-title":"Clin Chem Lab Med."},{"issue":"1","key":"2022011306531787300_CIT0291","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1515\/jpem-2020-0245","article-title":"Late diagnosis of 3\u03b2-Hydroxysteroid dehydrogenase deficiency: the pivotal role of gas chromatography-mass spectrometry urinary steroid metabolome analysis and a novel homozygous nonsense mutation in the HSD3B2 gene","volume":"34","author":"Fanis","year":"2021","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"Pt A","key":"2022011306531787300_CIT0292","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jsbmb.2015.10.011","article-title":"Phenotypic, metabolic, and molecular genetic characterization of six patients with congenital adrenal hyperplasia caused by novel mutations in the CYP11B1 gene","volume":"155","author":"Nguyen","year":"2016","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"2","key":"2022011306531787300_CIT0293","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1297\/cpe.25.37","article-title":"Classic and non-classic 21-hydroxylase deficiency can be discriminated from P450 oxidoreductase deficiency in Japanese infants by urinary steroid metabolites","volume":"25","author":"Koyama","year":"2016","journal-title":"Clin Pediatr Endocrinol."},{"issue":"4","key":"2022011306531787300_CIT0294","doi-asserted-by":"crossref","first-page":"E970","DOI":"10.1152\/ajpendo.00495.2006","article-title":"Sexual dimorphism in cortisol secretion starts after age 10 in healthy children: urinary cortisol metabolite excretion rates during growth","volume":"293","author":"Wudy","year":"2007","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"1","key":"2022011306531787300_CIT0295","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/hmg\/ddm285","article-title":"A novel Usher protein network at the periciliary reloading point between molecular transport machineries in vertebrate photoreceptor cells","volume":"17","author":"Maerker","year":"2008","journal-title":"Hum Mol Genet."},{"issue":"Pt B","key":"2022011306531787300_CIT0296","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jsbmb.2016.08.006","article-title":"The urinary steroidome of treated children with classic 21-hydroxylase deficiency","volume":"165","author":"Kamrath","year":"2017","journal-title":"J Steroid Biochem Mol Biol."},{"key":"2022011306531787300_CIT0297","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2019-00438","article-title":"Height velocity defined metabolic control in children with congenital adrenal hyperplasia using urinary GC-MS analysis","volume":"104","author":"Kamrath","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"2022011306531787300_CIT0298","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jsbmb.2017.12.016","article-title":"Androgen excess is due to elevated 11-oxygenated androgens in treated children with congenital adrenal hyperplasia","volume":"178","author":"Kamrath","year":"2018","journal-title":"J Steroid Biochem Mol Biol."},{"key":"2022011306531787300_CIT0299","doi-asserted-by":"crossref","first-page":"105724","DOI":"10.1016\/j.jsbmb.2020.105724","article-title":"The A-ring reduction of 11-ketotestosterone is efficiently catalysed by AKR1D1 and SRD5A2 but not SRD5A1","volume":"202","author":"Barnard","year":"2020","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"3","key":"2022011306531787300_CIT0300","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11306-010-0217-8","article-title":"A steroid metabolomic approach to 17\u03b1-hydroxylase\/17,20 lyase deficiency","volume":"6","author":"Tiosano","year":"2010","journal-title":"Metabolomics."},{"issue":"11","key":"2022011306531787300_CIT0301","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1210\/jc.2016-1754","article-title":"Steroid metabolomic disease signature of nonsyndromic childhood obesity","volume":"101","author":"Gawlik","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"2022011306531787300_CIT0302","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.steroids.2014.07.003","article-title":"Peer group normalization and urine to blood context in steroid metabolomics: the case of CAH and obesity","volume":"88","author":"Vitkin","year":"2014","journal-title":"Steroids."},{"key":"2022011306531787300_CIT0303","doi-asserted-by":"crossref","first-page":"154354","DOI":"10.1016\/j.metabol.2020.154354","article-title":"Urinary GC-MS steroid metabotyping in treated children with congenital adrenal hyperplasia","volume":"112","author":"Kamrath","year":"2020","journal-title":"Metabolism."},{"issue":"9","key":"2022011306531787300_CIT0304","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1194\/jlr.D061499","article-title":"Simultaneous quantification of cholesterol sulfate, androgen sulfates, and progestagen sulfates in human serum by LC-MS\/MS","volume":"56","author":"S\u00e1nchez-Guijo","year":"2015","journal-title":"J Lipid Res."},{"issue":"5","key":"2022011306531787300_CIT0305","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-16-0953","article-title":"Steroid hormone analysis in diagnosis and treatment of DSD: position paper of EU COST Action BM 1303 \u2018DSDnet\u2019","volume":"176","author":"Kulle","year":"2017","journal-title":"Eur J Endocrinol."},{"issue":"12","key":"2022011306531787300_CIT0306","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1073\/pnas.85.12.4436","article-title":"Characterization of frequent deletions causing steroid 21-hydroxylase deficiency","volume":"85","author":"White","year":"1988","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"2","key":"2022011306531787300_CIT0307","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1530\/EJE-11-0119","article-title":"Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche","volume":"165","author":"Ghizzoni","year":"2011","journal-title":"Eur J Endocrinol."},{"issue":"10-11","key":"2022011306531787300_CIT0308","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.steroids.2011.04.010","article-title":"Molecular analysis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Hong Kong Chinese patients","volume":"76","author":"Chan","year":"2011","journal-title":"Steroids."},{"issue":"1","key":"2022011306531787300_CIT0309","first-page":"44","article-title":"Multiplex ligation-dependent probe amplification assay for diagnosis of congenital adrenal hyperplasia","volume":"41","author":"Jang","year":"2011","journal-title":"Ann Clin Lab Sci."},{"issue":"1","key":"2022011306531787300_CIT0310","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.fertnstert.2018.11.041","article-title":"Prenatal genetic testing and treatment for congenital adrenal hyperplasia","volume":"111","author":"Simpson","year":"2019","journal-title":"Fertil Steril."},{"key":"2022011306531787300_CIT0311","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1203\/00006450-199305001-00011","article-title":"Prenatal treatment of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency: European experience in 223 pregnancies at risk","volume":"33","author":"Forest","year":"1993","journal-title":"Ped Res."},{"issue":"2","key":"2022011306531787300_CIT0312","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0022-3476(75)80498-7","article-title":"Letter: Elevated amniotic fluid concentration of 17 alpha-hydroxyprogesterone in congenital adrenal hyperplasia","volume":"86","author":"Frasier","year":"1975","journal-title":"J Pediatr."},{"issue":"7412","key":"2022011306531787300_CIT0313","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0140-6736(65)90864-0","article-title":"Diagnosis of the adrenogenital syndrome before birth","volume":"2","author":"Jeffcoate","year":"1965","journal-title":"Lancet."},{"issue":"8126","key":"2022011306531787300_CIT0314","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(79)91789-6","article-title":"Prenatal diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency) by HLA typing","volume":"1","author":"Pollack","year":"1979","journal-title":"Lancet."},{"issue":"3","key":"2022011306531787300_CIT0315","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/01.ten.0000081690.21823.af","article-title":"Prenatal therapy in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: retrospective follow-up study of 253 treated pregnancies in 215 families","volume":"13","author":"Forest","year":"2003","journal-title":"Endocrinologist."},{"issue":"4","key":"2022011306531787300_CIT0316","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/uog.20353","article-title":"Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis","volume":"54","author":"Salomon","year":"2019","journal-title":"Ultrasound Obstet Gynecol."},{"issue":"12","key":"2022011306531787300_CIT0317","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/clinchem\/46.12.1903","article-title":"Fetal DNA in maternal plasma: biology and diagnostic applications","volume":"46","author":"Lo","year":"2000","journal-title":"Clin Chem."},{"issue":"9076","key":"2022011306531787300_CIT0318","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet."},{"issue":"19","key":"2022011306531787300_CIT0319","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1001\/jama.1993.03510190113036","article-title":"Isolating fetal cells from maternal blood. Advances in prenatal diagnosis through molecular technology","volume":"270","author":"Simpson","year":"1993","journal-title":"JAMA."},{"issue":"2","key":"2022011306531787300_CIT0320","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1073\/pnas.93.2.705","article-title":"Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum","volume":"93","author":"Bianchi","year":"1996","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"6","key":"2022011306531787300_CIT0321","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/jama.2011.1114","article-title":"Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis","volume":"306","author":"Devaney","year":"2011","journal-title":"JAMA."},{"issue":"4","key":"2022011306531787300_CIT0322","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1210\/jc.2013-2895","article-title":"New management strategy of pregnancies at risk of congenital adrenal hyperplasia using fetal sex determination in maternal serum: French cohort of 258 cases (2002-2011)","volume":"99","author":"Tardy-Guidollet","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022011306531787300_CIT0323","doi-asserted-by":"crossref","first-page":"E1022","DOI":"10.1210\/jc.2014-1118","article-title":"Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma","volume":"99","author":"New","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0324","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/bioe.12534","article-title":"Refining the ethics of preimplantation genetic diagnosis: a plea for contextualized proportionality","volume":"33","author":"Dondorp","year":"2019","journal-title":"Bioethics."},{"issue":"7","key":"2022011306531787300_CIT0325","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/pd.2552","article-title":"Preimplantation genetic diagnosis at 20 years","volume":"30","author":"Simpson","year":"2010","journal-title":"Prenat Diagn."},{"issue":"4","key":"2022011306531787300_CIT0326","first-page":"188","article-title":"Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society","volume":"58","author":"Clayton","year":"2002","journal-title":"Horm Res."},{"issue":"4","key":"2022011306531787300_CIT0327","doi-asserted-by":"crossref","first-page":"320","DOI":"10.7326\/0003-4819-136-4-200202190-00012","article-title":"NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"136","author":"Merke","year":"2002","journal-title":"Ann Intern Med."},{"issue":"1","key":"2022011306531787300_CIT0328","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1210\/jcem-33-1-14","article-title":"Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects","volume":"33","author":"Weitzman","year":"1971","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0329","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/10253890701727874","article-title":"Impact of stressors in a natural context on release of cortisol in healthy adult humans: a meta-analysis","volume":"11","author":"Michaud","year":"2008","journal-title":"Stress."},{"issue":"9","key":"2022011306531787300_CIT0330","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1210\/jc.2009-0630","article-title":"Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion","volume":"94","author":"Bryan","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022011306531787300_CIT0331","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2265.2006.02544.x","article-title":"Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia","volume":"65","author":"Merza","year":"2006","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"17","key":"2022011306531787300_CIT0332","first-page":"10","article-title":"Congenital adrenal hyperplasia","volume":"2017","author":"El-Maouche","journal-title":"Lancet."},{"key":"2022011306531787300_CIT0333","doi-asserted-by":"crossref","first-page":"U63","DOI":"10.1530\/eje.0.151u063","article-title":"Prenatal treatment of congenital adrenal hyperplasia","volume":"151","author":"Lajic","year":"2004","journal-title":"Eur J Endocrinol."},{"issue":"4","key":"2022011306531787300_CIT0334","first-page":"1210","article-title":"Failure of cortisone acetate treatment in congenital adrenal hyperplasia because of defective 11beta-hydroxysteroid dehydrogenase reductase activity","volume":"84","author":"Nordenstr\u00f6m","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022011306531787300_CIT0335","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1515\/JPEM.2005.18.1.97","article-title":"Adrenocorticotropin hypersecretion and pituitary microadenoma following bilateral adrenalectomy in a patient with classic 21-hydroxylase deficiency","volume":"18","author":"Charmandari","year":"2005","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"9477","key":"2022011306531787300_CIT0336","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(05)66736-0","article-title":"Congenital adrenal hyperplasia","volume":"365","author":"Merke","year":"2005","journal-title":"Lancet."},{"issue":"3","key":"2022011306531787300_CIT0337","doi-asserted-by":"crossref","first-page":"e1729","DOI":"10.1210\/clinem\/dgaa071","article-title":"Pharmacokinetic\/pharmacodynamic evaluation of hydrocortisone therapy in pediatric patients with congenital adrenal hyperplasia","volume":"105","author":"Melin","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2022011306531787300_CIT0338","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1210\/jc.2008-0519","article-title":"Control of childhood congenital adrenal hyperplasia and sleep activity and quality with morning or evening glucocorticoid therapy","volume":"93","author":"German","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"2022011306531787300_CIT0339","first-page":"CD012517","article-title":"Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia","volume":"3","author":"Ng","year":"2020","journal-title":"Cochrane Database Syst Rev."},{"key":"2022011306531787300_CIT0340","doi-asserted-by":"crossref","first-page":"275213","DOI":"10.1186\/1687-9856-2010-275213","article-title":"Guidelines for the development of comprehensive care centers for congenital adrenal hyperplasia: guidance from the CARES foundation initiative","volume":"2010","author":"Auchus","year":"2010","journal-title":"Int J Pediatr Endocrinol."},{"issue":"10","key":"2022011306531787300_CIT0341","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1515\/jpem-2019-0006","article-title":"Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty","volume":"32","author":"Pijnenburg-Kleizen","year":"2019","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"1","key":"2022011306531787300_CIT0342","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1210\/jc.2017-01595","article-title":"Iatrogenic Cushing syndrome in a child with congenital adrenal hyperplasia: erroneous compounding of hydrocortisone","volume":"103","author":"Barillas","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0343","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1530\/EJE-17-0248","article-title":"Quality of compounded hydrocortisone capsules used in the treatment of children","volume":"177","author":"Neumann","year":"2017","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2022011306531787300_CIT0344","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1210\/jcem.86.1.7275","article-title":"Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasia","volume":"86","author":"Merke","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0345","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/17446651.2018.1455496","article-title":"Immediate-release granule formulation of hydrocortisone, Alkindi\u00ae, for treatment of paediatric adrenal insufficiency (Infacort development programme)","volume":"13","author":"Porter","year":"2018","journal-title":"Expert Rev Endocrinol Metab."},{"issue":"1","key":"2022011306531787300_CIT0346","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/cen.13447","article-title":"Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency","volume":"88","author":"Neumann","year":"2018","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"9","key":"2022011306531787300_CIT0347","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1515\/JPEM.2001.14.9.1649","article-title":"Salt wasting in simple virilizing congenital adrenal hyperplasia","volume":"14","author":"Frisch","year":"2001","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"1","key":"2022011306531787300_CIT0348","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1210\/jc.2006-0964","article-title":"Aldosterone-to-renin ratio as a marker for disease severity in 21-hydroxylase deficiency congenital adrenal hyperplasia","volume":"92","author":"Nimkarn","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022011306531787300_CIT0349","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF01959473","article-title":"Sodium chloride supplement at diagnosis and during infancy in children with salt-losing 21-hydroxylase deficiency","volume":"150","author":"Mullis","year":"1990","journal-title":"Eur J Pediatr."},{"issue":"1","key":"2022011306531787300_CIT0350","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000481775","article-title":"Sodium chloride supplementation is not routinely performed in the majority of German and Austrian infants with classic salt-wasting congenital adrenal hyperplasia and has no effect on linear growth and hydrocortisone or fludrocortisone dose","volume":"89","author":"Bonfig","year":"2018","journal-title":"Horm Res Paediatr."},{"issue":"4","key":"2022011306531787300_CIT0351","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/cen.12653","article-title":"Variation in absorption and half-life of hydrocortisone influence plasma cortisol concentrations","volume":"82","author":"Hindmarsh","year":"2015","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"3","key":"2022011306531787300_CIT0352","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1067\/S0022-3476(03)00294-4","article-title":"Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency","volume":"143","author":"Punthakee","year":"2003","journal-title":"J Pediatr."},{"issue":"4","key":"2022011306531787300_CIT0353","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1542\/peds.106.4.767","article-title":"Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth","volume":"106","author":"Rivkees","year":"2000","journal-title":"Pediatrics."},{"issue":"5","key":"2022011306531787300_CIT0354","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1210\/jc.2006-2109","article-title":"Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty","volume":"92","author":"Bonfig","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022011306531787300_CIT0355","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1210\/jcem.86.6.7522","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty","volume":"86","author":"Charmandari","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022011306531787300_CIT0356","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/cen.12053","article-title":"The challenge of delivering endocrine care and successful transition to adult services in adolescents with congenital adrenal hyperplasia: experience in a single centre over 18 years","volume":"78","author":"Gleeson","year":"2013","journal-title":"Clin Endocrinol (Oxf)."},{"key":"2022011306531787300_CIT0357","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000487523","article-title":"Transition of care from childhood to adulthood: congenital adrenal hyperplasia","volume":"33","author":"Bachelot","year":"2018","journal-title":"Endocr Dev."},{"issue":"11","key":"2022011306531787300_CIT0358","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1210\/jc.2010-0917","article-title":"Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients","volume":"95","author":"Arlt","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2022011306531787300_CIT0359","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/j.jpedsurg.2019.01.062","article-title":"Gender dysphoria and XX congenital adrenal hyperplasia: how frequent is it? Is male-sex rearing a good idea?","volume":"54","author":"de Jesus","year":"2019","journal-title":"J Pediatr Surg."},{"issue":"5","key":"2022011306531787300_CIT0360","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jpag.2020.05.005","article-title":"Identity, sexuality, and parenthood in women with congenital adrenal hyperplasia","volume":"33","author":"Engberg","year":"2020","journal-title":"J Pediatr Adolesc Gynecol."},{"issue":"1","key":"2022011306531787300_CIT0361","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1038\/s41598-017-05560-1","article-title":"MiR-30a targets IL-1\u03b1 and regulates islet functions as an inflammation buffer and response factor","volume":"7","author":"Jiang","year":"2017","journal-title":"Sci Rep."},{"key":"2022011306531787300_CIT0362","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.ghir.2004.03.015","article-title":"Congenital adrenal hyperplasia: transitional care","volume":"14","author":"Hughes","year":"2004","journal-title":"Growth Horm IGF Res."},{"issue":"2-03","key":"2022011306531787300_CIT0363","first-page":"171","article-title":"Review of health problems in adult patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"127","author":"Reisch","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes."},{"key":"2022011306531787300_CIT0364","doi-asserted-by":"crossref","first-page":"105540","DOI":"10.1016\/j.jsbmb.2019.105540","article-title":"Effect of androgen excess and glucocorticoid exposure on metabolic risk profiles in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"197","author":"Paizoni","year":"2020","journal-title":"J Steroid Biochem Mol Biol."},{"key":"2022011306531787300_CIT0365","doi-asserted-by":"crossref","first-page":"105734","DOI":"10.1016\/j.jsbmb.2020.105734","article-title":"Effects of androgen excess and glucocorticoid exposure on bone health in adult patients with 21-hydroxylase deficiency","volume":"204","author":"Auer","year":"2020","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"12","key":"2022011306531787300_CIT0366","doi-asserted-by":"crossref","first-page":"E2715","DOI":"10.1210\/jc.2014-2957","article-title":"Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"99","author":"Falhammar","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022011306531787300_CIT0367","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1210\/js.2019-00136","article-title":"Glucocorticoid regimens in the treatment of congenital adrenal hyperplasia: a systematic review and meta-analysis","volume":"3","author":"Whittle","year":"2019","journal-title":"J Endocr Soc."},{"issue":"4","key":"2022011306531787300_CIT0368","first-page":"196","article-title":"Management of congenital adrenal hyperplasia: results of the ESPE questionnaire","volume":"58","author":"Riepe","year":"2002","journal-title":"Horm Res."},{"key":"2022011306531787300_CIT0369","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.mce.2015.01.039","article-title":"Management considerations for the adult with congenital adrenal hyperplasia","volume":"408","author":"Auchus","year":"2015","journal-title":"Mol Cell Endocrinol."},{"issue":"7","key":"2022011306531787300_CIT0370","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/humrep\/den118","article-title":"Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"23","author":"Hagenfeldt","year":"2008","journal-title":"Hum Reprod."},{"issue":"2","key":"2022011306531787300_CIT0371","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/cen.12045","article-title":"Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia","volume":"78","author":"Han","year":"2013","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"2","key":"2022011306531787300_CIT0372","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/cen.14126","article-title":"Efficacy and safety of prenatal dexamethasone treatment in offspring at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a systematic review and meta-analysis","volume":"92","author":"Xu","year":"2020","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"3","key":"2022011306531787300_CIT0373","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.beem.2015.01.005","article-title":"Fetal endocrine therapy for congenital adrenal hyperplasia should not be done","volume":"29","author":"Miller","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"5","key":"2022011306531787300_CIT0374","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1055\/s-0032-1324723","article-title":"An update on prenatal diagnosis and treatment of congenital adrenal hyperplasia","volume":"30","author":"New","year":"2012","journal-title":"Semin Reprod Med."},{"issue":"6","key":"2022011306531787300_CIT0375","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1210\/jc.2012-1222","article-title":"Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint","volume":"97","author":"Hirvikoski","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022011306531787300_CIT0376","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1210\/er.2018-00258","article-title":"Testicular adrenal rest tumors: current insights on prevalence, characteristics, origin, and treatment","volume":"40","author":"Engels","year":"2019","journal-title":"Endocr Rev."},{"key":"2022011306531787300_CIT0377","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.urology.2019.03.005","article-title":"Three cases of testicular adrenal rest tumors in congenital adrenal hyperplasia-a diagnostic and therapeutic challenge","volume":"129","author":"Lottspeich","year":"2019","journal-title":"Urology."},{"issue":"2","key":"2022011306531787300_CIT0378","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1210\/jc.2011-1926","article-title":"Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation","volume":"97","author":"Johannsson","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0379","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S2213-8587(17)30398-4","article-title":"Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial","volume":"6","author":"Isidori","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"9","key":"2022011306531787300_CIT0380","first-page":"3082","article-title":"Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning","volume":"84","author":"Plat","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022011306531787300_CIT0381","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1210\/jc.2008-2380","article-title":"Modified-release hydrocortisone to provide circadian cortisol profiles","volume":"94","author":"Debono","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022011306531787300_CIT0382","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/cen.12316","article-title":"An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure","volume":"80","author":"Whitaker","year":"2014","journal-title":"Clin Endocrinol (Oxf)."},{"key":"2022011306531787300_CIT0383","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa046.214","article-title":"OR25-02 A Phase 3 study of a modified-release hydrocortisone in the treatment of congenital adrenal hyperplasia","volume":"4","author":"Merke","year":"2020","journal-title":"J Endocr Soc."},{"issue":"1","key":"2022011306531787300_CIT0384","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1210\/clinem\/dgz055","article-title":"Plasma renin measurements are unrelated to mineralocorticoid replacement dose in patients with primary adrenal insufficiency","volume":"105","author":"Pofi","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022011306531787300_CIT0385","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1210\/jc.2015-1023","article-title":"Profiles of 21-carbon steroids in 21-hydroxylase deficiency","volume":"100","author":"Turcu","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0386","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1515\/cclm-2014-0375","article-title":"Salivary morning androstenedione and 17\u03b1-OH progesterone levels in childhood and puberty in patients with classic congenital adrenal hyperplasia","volume":"53","author":"de Groot","year":"2015","journal-title":"Clin Chem Lab Med."},{"issue":"2","key":"2022011306531787300_CIT0387","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-3476(99)70413-0","article-title":"Home monitoring of 17 hydroxyprogesterone levels in congenital adrenal hyperplasia with filter paper blood samples [see comments]","volume":"134","author":"Bode","year":"1999","journal-title":"J Pediatr."},{"issue":"7-8","key":"2022011306531787300_CIT0388","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1515\/jpem-2014-0303","article-title":"Therapy monitoring in congenital adrenal hyperplasia by dried blood samples","volume":"28","author":"Wieacker","year":"2015","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"6","key":"2022011306531787300_CIT0389","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1530\/EJE-15-0064","article-title":"Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers","volume":"173","author":"Debono","year":"2015","journal-title":"Eur J Endocrinol."},{"issue":"12","key":"2022011306531787300_CIT0390","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1210\/jc.2019-00031","article-title":"Measurement of salivary adrenal-specific androgens as biomarkers of therapy control in 21-hydroxylase deficiency","volume":"104","author":"Bacila","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"2022011306531787300_CIT0391","doi-asserted-by":"crossref","first-page":"105389","DOI":"10.1016\/j.jsbmb.2019.105389","article-title":"Advancement in steroid hormone analysis by LC-MS\/MS in clinical routine diagnostics - a three year recap from serum cortisol to dried blood 17\u03b1-hydroxyprogesterone","volume":"192","author":"Gaudl","year":"2019","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"4","key":"2022011306531787300_CIT0392","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1530\/EJE-17-0895","article-title":"Poor compliance and increased mortality, depression and healthcare costs in patients with congenital adrenal hyperplasia","volume":"178","author":"Jenkins-Jones","year":"2018","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2022011306531787300_CIT0393","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/jc.2014-3191","article-title":"High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study","volume":"100","author":"Hahner","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0394","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1530\/EJE-15-0775","article-title":"Children with classic congenital adrenal hyperplasia experience salt loss and hypoglycemia: evaluation of adrenal crises during the first 6 years of life","volume":"174","author":"Odenwald","year":"2016","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2022011306531787300_CIT0395","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/EJE-12-0161","article-title":"Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency","volume":"167","author":"Reisch","year":"2012","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"2022011306531787300_CIT0396","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/cen.13309","article-title":"Risk factors for hospitalization of children with congenital adrenal hyperplasia","volume":"86","author":"Yang","year":"2017","journal-title":"Clin Endocrinol (Oxf)."},{"key":"2022011306531787300_CIT0397","doi-asserted-by":"crossref","first-page":"5748264","DOI":"10.1155\/2016\/5748264","article-title":"Hospital admission patterns in children with CAH: admission rates and adrenal crises decline with age","volume":"2016","author":"Rushworth","year":"2016","journal-title":"Int J Endocrinol."},{"issue":"1","key":"2022011306531787300_CIT0398","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1210\/clinem\/dgaa694","article-title":"Real-world estimates of adrenal insufficiency-related adverse events in children with congenital adrenal hyperplasia","volume":"106","author":"Ali","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0399","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1210\/clinem\/dgz006","article-title":"Increased infection risk in Addison\u2019s disease and congenital adrenal hyperplasia","volume":"105","author":"Tresoldi","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022011306531787300_CIT0400","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1210\/jc.2018-00208","article-title":"Longitudinal assessment of illnesses, stress dosing, and illness sequelae in patients with congenital adrenal hyperplasia","volume":"103","author":"El-Maouche","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0401","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/adc.70.3.214","article-title":"Presentation, acute illness, and learning difficulties in salt wasting 21-hydroxylase deficiency","volume":"70","author":"Donaldson","year":"1994","journal-title":"Arch Dis Child."},{"issue":"19","key":"2022011306531787300_CIT0402","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJM200011093431903","article-title":"Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency","volume":"343","author":"Merke","year":"2000","journal-title":"N Engl J Med."},{"issue":"2","key":"2022011306531787300_CIT0403","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0404","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1530\/EJE-14-0824","article-title":"Extensive expertise in endocrinology. Adrenal crisis","volume":"172","author":"Allolio","year":"2015","journal-title":"Eur J Endocrinol."},{"issue":"9","key":"2022011306531787300_CIT0405","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJMra1807486","article-title":"Adrenal crisis","volume":"381","author":"Rushworth","year":"2019","journal-title":"N Engl J Med."},{"issue":"1","key":"2022011306531787300_CIT0406","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1297\/cpe.18.23","article-title":"Stress doses of glucocorticoids cannot prevent progression of all adrenal crises","volume":"18","author":"Aso","year":"2009","journal-title":"Clin Pediatr Endocrinol."},{"issue":"2","key":"2022011306531787300_CIT0407","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/cen.14196","article-title":"The effect of patient-managed stress dosing on electrolytes and blood pressure in acute illness in children with adrenal insufficiency","volume":"93","author":"Chrisp","year":"2020","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"7","key":"2022011306531787300_CIT0408","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1210\/clinem\/dgaa133","article-title":"Prevention of adrenal crisis: cortisol responses to major stress compared to stress dose hydrocortisone delivery","volume":"105","author":"Prete","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2022011306531787300_CIT0409","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1210\/jc.2013-2148","article-title":"Cortisol response to operative stress with anesthesia in healthy children","volume":"98","author":"Taylor","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022011306531787300_CIT0410","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1210\/jc.2008-1582","article-title":"Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members","volume":"94","author":"Bidet","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022011306531787300_CIT0411","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1530\/EJE-11-0019","article-title":"Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families","volume":"164","author":"Nandagopal","year":"2011","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2022011306531787300_CIT0412","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.beem.2008.09.009","article-title":"Therapeutic management of adrenal insufficiency","volume":"23","author":"Hahner","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"1","key":"2022011306531787300_CIT0413","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/EJE-12-1094","article-title":"A glucocorticoid education group meeting: an effective strategy for improving self-management to prevent adrenal crisis","volume":"169","author":"Repping-Wuts","year":"2013","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2022011306531787300_CIT0414","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40348-020-00100-w","article-title":"Genotype-phenotype correlations in children and adolescents with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"7","author":"D\u00f6rr","year":"2020","journal-title":"Mol Cell Pediatr."},{"key":"2022011306531787300_CIT0415","first-page":"224","article-title":"Non classic CAH; targets of treatment and transition","volume":"12","author":"McCann-Crosby","year":"2014","journal-title":"Pediatr Endocr Rev."},{"key":"2022011306531787300_CIT0416","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4419-8002-1_9","article-title":"Medical treatment of classic and nonclassic congenital adrenal hyperplasia","volume":"707","author":"Speiser","year":"2011","journal-title":"Adv Exp Med Biol."},{"issue":"8","key":"2022011306531787300_CIT0417","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.steroids.2013.04.010","article-title":"Non-classic congenital adrenal hyperplasia","volume":"78","author":"Witchel","year":"2013","journal-title":"Steroids."},{"issue":"1","key":"2022011306531787300_CIT0418","first-page":"142","article-title":"Extensive clinical-experience - nonclassical 21-hydroxylase deficiency (vol 91, pg 4205, 2006)","volume":"92","author":"New","year":"2007","journal-title":"J Clin Endocrinol Metabol."},{"issue":"3","key":"2022011306531787300_CIT0419","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000337217","article-title":"Absence of clinically relevant growth acceleration in untreated children with non-classical congenital adrenal hyperplasia","volume":"77","author":"Pijnenburg-Kleizen","year":"2012","journal-title":"Horm Res Paediatr."},{"issue":"4","key":"2022011306531787300_CIT0420","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1210\/jc.2005-1701","article-title":"Absence of increased height velocity in the first year of life in untreated children with simple virilizing congenital adrenal hyperplasia","volume":"91","author":"Claahsen-van der Grinten","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022011306531787300_CIT0421","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/apa.12147","article-title":"Adult height of subjects with nonclassical 21-hydroxylase deficiency","volume":"102","author":"Eyal","year":"2013","journal-title":"Acta Paediatr."},{"issue":"8 Suppl 3","key":"2022011306531787300_CIT0422","first-page":"91","article-title":"Growth and final height in classical and nonclassical 21-hydroxylase deficiency","volume":"12","author":"New","year":"1989","journal-title":"J Endocrinol Invest."},{"issue":"8","key":"2022011306531787300_CIT0423","first-page":"883","article-title":"Growth and pubertal characteristics in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"20","author":"Trinh","year":"2007","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"1","key":"2022011306531787300_CIT0424","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2011.05.004","article-title":"Congenital adrenal hyperplasia \u2013 pharmacologic interventions from the prenatal phase to adulthood","volume":"132","author":"Claahsen-van der Grinten","year":"2011","journal-title":"Pharmacol Ther."},{"issue":"6","key":"2022011306531787300_CIT0425","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1067\/mob.2000.108020","article-title":"21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study","volume":"183","author":"Moran","year":"2000","journal-title":"Am J Obstet Gynecol."},{"key":"2022011306531787300_CIT0426","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3389\/fendo.2019.00366","article-title":"Management of the female with non-classical congenital adrenal hyperplasia (NCCAH): a patient-oriented approach","volume":"10","author":"Livadas","year":"2019","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"3","key":"2022011306531787300_CIT0427","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1530\/EJE-18-0712","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency","volume":"180","author":"Nordenstr\u00f6m","year":"2019","journal-title":"Eur J Endocrinol."},{"issue":"7","key":"2022011306531787300_CIT0428","first-page":"298","article-title":"Congenital adrenal hyperplasia as a cause of adrenal incidentaloma","volume":"75","author":"Buitenwerf","year":"2017","journal-title":"Neth J Med."},{"issue":"3","key":"2022011306531787300_CIT0429","first-page":"685","article-title":"Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia","volume":"74","author":"Jaresch","year":"1992","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022011306531787300_CIT0430","doi-asserted-by":"crossref","first-page":"736","DOI":"10.4158\/EP151085.RA","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency presenting as adrenal incidentaloma: a systematic review and meta-analysis","volume":"22","author":"Falhammar","year":"2016","journal-title":"Endocr Pract."},{"issue":"4","key":"2022011306531787300_CIT0431","article-title":"Interventions for hirsutism (excluding laser and photoepilation therapy alone)","author":"van Zuuren","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"issue":"1","key":"2022011306531787300_CIT0432","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2006.09.025","article-title":"A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women","volume":"57","author":"Hamzavi","year":"2007","journal-title":"J Am Acad Dermatol."},{"issue":"3","key":"2022011306531787300_CIT0433","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1210\/jcem-70-3-642","article-title":"Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia","volume":"70","author":"Spritzer","year":"1990","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022011306531787300_CIT0434","first-page":"CD007628","article-title":"Interventions for female pattern hair loss","author":"van Zuuren","year":"2012","journal-title":"Cochrane Database Syst Rev."},{"issue":"3","key":"2022011306531787300_CIT0435","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1530\/EJE-11-0828","article-title":"Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia","volume":"166","author":"Falhammar","year":"2012","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2022011306531787300_CIT0436","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1530\/EJE-17-0862","article-title":"Gonadal function in adult male patients with congenital adrenal hyperplasia","volume":"178","author":"Engels","year":"2018","journal-title":"Eur J Endocrinol."},{"issue":"4","key":"2022011306531787300_CIT0437","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1530\/EC-18-0097","article-title":"Testicular adrenal rest tumors in boys with 21-hydroxylase deficiency, timely diagnosis and follow-up","volume":"7","author":"Kocova","year":"2018","journal-title":"Endocr Connect."},{"issue":"7","key":"2022011306531787300_CIT0438","first-page":"2014","article-title":"Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency","volume":"80","author":"Mercado","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022011306531787300_CIT0439","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2265.2010.03826.x","article-title":"Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia because of 21-hydroxylase (CYP21A2) deficiency: a systematic review and meta-analyses","volume":"73","author":"Merc\u00e8 Fern\u00e1ndez-Balsells","year":"2010","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"13","key":"2022011306531787300_CIT0440","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/jama.1997.03540370067039","article-title":"How safe is long-term prenatal glucocorticoid treatment?","volume":"277","author":"Seckl","year":"1997","journal-title":"JAMA."},{"issue":"1","key":"2022011306531787300_CIT0441","first-page":"186","article-title":"Challenges in prenatal treatment with dexamethasone","volume":"16","author":"McCann-Crosby","year":"2018","journal-title":"Pediatr Endocrinol Rev."},{"issue":"5","key":"2022011306531787300_CIT0442","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10897-012-9508-8","article-title":"Prenatal treatment of congenital adrenal hyperplasia-not standard of care","volume":"21","author":"Witchel","year":"2012","journal-title":"J Genet Couns."},{"issue":"3","key":"2022011306531787300_CIT0443","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11673-012-9384-9","article-title":"Prenatal dexamethasone for congenital adrenal hyperplasia: an ethics canary in the modern medical mine","volume":"9","author":"Dreger","year":"2012","journal-title":"J Bioeth Inq."},{"issue":"3","key":"2022011306531787300_CIT0444","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/ajo.12423","article-title":"Preventing female virilisation in congenital adrenal hyperplasia: the controversial role of antenatal dexamethasone","volume":"56","author":"Heland","year":"2016","journal-title":"Aust N Z J Obstet Gynaecol."},{"issue":"9","key":"2022011306531787300_CIT0445","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2009-2631","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline","volume":"95","author":"Speiser","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022011306531787300_CIT0446","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/bdrb.20341","article-title":"The potential role for corticosterone in the induction of cleft palate in mice after treatment with a selective NK-1 receptor antagonist, casopitant (GW679769B)","volume":"95","author":"Ziejewski","year":"2012","journal-title":"Birth Defects Res B Dev Reprod Toxicol."},{"issue":"3","key":"2022011306531787300_CIT0447","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1203\/00006450-199809000-00009","article-title":"Prenatal dexamethasone causes oligonephronia, sodium retention, and higher blood pressure in the offspring","volume":"44","author":"Celsi","year":"1998","journal-title":"Pediatr Res."},{"issue":"1","key":"2022011306531787300_CIT0448","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1152\/ajpregu.00481.2006","article-title":"Maternal dexamethasone treatment at midgestation reduces nephron number and alters renal gene expression in the fetal spiny mouse","volume":"292","author":"Dickinson","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"2022011306531787300_CIT0449","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.steroids.2014.03.006","article-title":"Morpho-functional characteristics of rat fetal thyroid gland are affected by prenatal dexamethasone exposure","volume":"84","author":"Manojlovi\u0107-Stojanoski","year":"2014","journal-title":"Steroids."},{"issue":"6","key":"2022011306531787300_CIT0450","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1161\/01.HYP.27.6.1200","article-title":"Inhibition of 11-beta-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring","volume":"27","author":"Lindsay","year":"1996","journal-title":"Hypertension."},{"issue":"10","key":"2022011306531787300_CIT0451","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1172\/JCI1567","article-title":"Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring","volume":"101","author":"Nyirenda","year":"1998","journal-title":"J Clin Invest."},{"issue":"4","key":"2022011306531787300_CIT0452","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1210\/en.2009-1088","article-title":"Prenatal dexamethasone programs expression of genes in liver and adipose tissue and increased hepatic lipid accumulation but not obesity on a high-fat diet","volume":"151","author":"Drake","year":"2010","journal-title":"Endocrinology."},{"issue":"4","key":"2022011306531787300_CIT0453","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1172\/JCI30982","article-title":"Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic-pituitary-adrenal axis function","volume":"117","author":"de Vries","year":"2007","journal-title":"J Clin Invest."},{"issue":"11","key":"2022011306531787300_CIT0454","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s001250050573","article-title":"Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone","volume":"39","author":"Lindsay","year":"1996","journal-title":"Diabetologia."},{"issue":"14","key":"2022011306531787300_CIT0455","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1523\/JNEUROSCI.4464-05.2006","article-title":"The mother or the fetus? 11beta-hydroxysteroid dehydrogenase type 2 null mice provide evidence for direct fetal programming of behavior by endogenous glucocorticoids","volume":"26","author":"Holmes","year":"2006","journal-title":"J Neurosci."},{"issue":"2","key":"2022011306531787300_CIT0456","first-page":"213","article-title":"Effect of corticosteroids on brain growth in fetal sheep","volume":"94","author":"Huang","year":"1999","journal-title":"Obstet Gynecol."},{"issue":"1","key":"2022011306531787300_CIT0457","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ajog.2004.06.065","article-title":"Effects into adulthood of single or repeated antenatal corticosteroids in sheep","volume":"192","author":"Moss","year":"2005","journal-title":"Am J Obstet Gynecol."},{"key":"2022011306531787300_CIT0458","first-page":"47","article-title":"Repeated, but not single, maternal administration of corticosteroids delays myelination in the brain of fetal sheep","volume":"4","author":"Quinlivan","year":"1999","journal-title":"Perinat Neonat Med."},{"issue":"2","key":"2022011306531787300_CIT0459","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-3806(90)90002-G","article-title":"Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus","volume":"53","author":"Uno","year":"1990","journal-title":"Brain Res Dev Brain Res."},{"key":"2022011306531787300_CIT0460","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jsbmb.2013.07.010","article-title":"Dexamethasone inhibits the maturation of newly formed neurons and glia supplemented with polyunsaturated fatty acids","volume":"138","author":"Heberden","year":"2013","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"3","key":"2022011306531787300_CIT0461","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1210\/en.2012-1980","article-title":"Glucocorticoid programming of the fetal male hippocampal epigenome","volume":"154","author":"Crudo","year":"2013","journal-title":"Endocrinology."},{"issue":"7","key":"2022011306531787300_CIT0462","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1210\/en.2012-1054","article-title":"Transgenerational effects of prenatal synthetic glucocorticoids on hypothalamic-pituitary-adrenal function","volume":"153","author":"Iqbal","year":"2012","journal-title":"Endocrinology."},{"issue":"2","key":"2022011306531787300_CIT0463","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1530\/JOE-13-0514","article-title":"Adrenal steroidogenesis following prenatal dexamethasone exposure in the spiny mouse","volume":"221","author":"Quinn","year":"2014","journal-title":"J Endocrinol."},{"issue":"7","key":"2022011306531787300_CIT0464","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1210\/en.2011-2160","article-title":"Prenatal synthetic glucocorticoid treatment changes DNA methylation states in male organ systems: multigenerational effects","volume":"153","author":"Crudo","year":"2012","journal-title":"Endocrinology."},{"issue":"1","key":"2022011306531787300_CIT0465","first-page":"135","article-title":"11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess","volume":"18","author":"White","year":"1997","journal-title":"Endocr Rev."},{"key":"2022011306531787300_CIT0466","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.reprotox.2017.02.006","article-title":"The relationship between maternal corticosteroid use and orofacial clefts-a meta-analysis","volume":"69","author":"Xiao","year":"2017","journal-title":"Reprod Toxicol."},{"issue":"12","key":"2022011306531787300_CIT0467","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa071453","article-title":"Long-term outcomes after repeat doses of antenatal corticosteroids","volume":"357","author":"Wapner","year":"2007","journal-title":"N Engl J Med."},{"key":"2022011306531787300_CIT0468","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1464-410X.2004.04707.x","article-title":"The virilized female: endocrine background","volume":"93","author":"Forest","year":"2004","journal-title":"BJU Int."},{"issue":"12","key":"2022011306531787300_CIT0469","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1210\/jcem.86.12.8072","article-title":"Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies","volume":"86","author":"New","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2022011306531787300_CIT0470","first-page":"3872","article-title":"Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia","volume":"83","author":"Lajic","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022011306531787300_CIT0471","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000348515","article-title":"Acute encephalopathy with unilateral cortical-subcortical lesions in two unrelated kindreds treated with glucocorticoids prenatally for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: established facts and novel insight","volume":"80","author":"Grunt","year":"2013","journal-title":"Horm Res Paediatr."},{"issue":"1","key":"2022011306531787300_CIT0472","first-page":"21","article-title":"Prenatal treatment with dexamethasone in suspected congenital adrenal hyperplasia and orofacial cleft: a case report and review of the literature","volume":"15","author":"Rijk","year":"2017","journal-title":"Pediatr Endocrinol Rev."},{"issue":"4","key":"2022011306531787300_CIT0473","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0306-4530(94)00070-0","article-title":"Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study","volume":"20","author":"Trautman","year":"1995","journal-title":"Psychoneuroendocrinology."},{"issue":"2","key":"2022011306531787300_CIT0474","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1210\/jc.2002-021129","article-title":"Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone","volume":"89","author":"Meyer-Bahlburg","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0475","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1210\/jc.2006-1340","article-title":"Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone","volume":"92","author":"Hirvikoski","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0476","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1530\/EJE-08-0280","article-title":"Long-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia: does dexamethasone cause behavioural problems?","volume":"159","author":"Hirvikoski","year":"2008","journal-title":"Eur J Endocrinol."},{"issue":"9","key":"2022011306531787300_CIT0477","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1111\/j.1651-2227.2011.02260.x","article-title":"Gender role behaviour in prenatally dexamethasone-treated children at risk for congenital adrenal hyperplasia \u2013 a pilot study","volume":"100","author":"Hirvikoski","year":"2011","journal-title":"Acta Paediatr."},{"issue":"1","key":"2022011306531787300_CIT0478","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1530\/EJE-11-0789","article-title":"Cognitive outcome of offspring from dexamethasone-treated pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"167","author":"Meyer-Bahlburg","year":"2012","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2022011306531787300_CIT0479","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/09297049.2012.745495","article-title":"Cognitive and social function in girls with congenital adrenal hyperplasia \u2013 influence of prenatally administered dexamethasone","volume":"20","author":"Maryniak","year":"2014","journal-title":"Child Neuropsychol."},{"issue":"10","key":"2022011306531787300_CIT0480","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1210\/jc.2016-1543","article-title":"Sex-dimorphic effects of prenatal treatment with dexamethasone","volume":"101","author":"Wallensteen","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"2022011306531787300_CIT0481","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.yhbeh.2017.11.004","article-title":"Evaluation of behavioral problems after prenatal dexamethasone treatment in Swedish children and adolescents at risk of congenital adrenal hyperplasia","volume":"98","author":"Wallensteen","year":"2018","journal-title":"Horm Behav."},{"key":"2022011306531787300_CIT0482","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.psyneuen.2018.02.033","article-title":"Prenatal dexamethasone treatment in the context of at risk CAH pregnancies: long-term behavioral and cognitive outcome","volume":"91","author":"Karlsson","year":"2018","journal-title":"Psychoneuroendocrinology."},{"issue":"1","key":"2022011306531787300_CIT0483","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1210\/js.2018-00377","article-title":"Epigenetic alterations associated with early prenatal dexamethasone treatment","volume":"3","author":"Karlsson","year":"2019","journal-title":"J Endocr Soc."},{"issue":"3","key":"2022011306531787300_CIT0484","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz145","article-title":"Exposure to glucocorticoids in the first part of fetal life is associated with insulin secretory defect in adult humans","volume":"105","author":"Riveline","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2022011306531787300_CIT0485","doi-asserted-by":"crossref","first-page":"e2439","DOI":"10.1210\/clinem\/dgaa280","article-title":"Perturbed beta-cell function and lipid profile after early prenatal dexamethasone exposure in individuals without CAH","volume":"105","author":"Wallensteen","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022011306531787300_CIT0486","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/cen.13441","article-title":"Cognitive impairment in adolescents and adults with congenital adrenal hyperplasia","volume":"87","author":"Karlsson","year":"2017","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"8","key":"2022011306531787300_CIT0487","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1210\/clinem\/dgaa340","article-title":"First trimester prenatal dexamethasone treatment is associated with alterations in brain structure at adult age","volume":"105","author":"Van\u2019t Westeinde","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0488","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2018-01566","article-title":"Persistent effects of antenatal synthetic glucocorticoids on endocrine stress reactivity from childhood to adolescence","volume":"104","author":"Ilg","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"19","key":"2022011306531787300_CIT0489","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2020.3937","article-title":"Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children","volume":"323","author":"R\u00e4ikk\u00f6nen","year":"2020","journal-title":"JAMA."},{"issue":"3","key":"2022011306531787300_CIT0490","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1210\/jc.2014-3809","article-title":"A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia","volume":"100","author":"Mallappa","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2022011306531787300_CIT0491","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1210\/jc.2016-1916","article-title":"A phase 2 study of continuous subcutaneous hydrocortisone infusion in adults with congenital adrenal hyperplasia","volume":"101","author":"Nella","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0492","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1210\/jcem.85.3.6462","article-title":"Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia","volume":"85","author":"Merke","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"2022011306531787300_CIT0493","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev-med-051418-060357","article-title":"Sex hormones and prostate cancer","volume":"71","author":"Auchus","year":"2020","journal-title":"Annu Rev Med."},{"key":"2022011306531787300_CIT0494","first-page":"SUN-LB2","article-title":"Abiraterone acetate added to physiologic hydrocortisone dosing safely controls androgen excess in adult women with classical 21-hydroxylase deficiency","volume":"33","author":"Auchus","year":"2012","journal-title":"Endocr Rev."},{"issue":"4","key":"2022011306531787300_CIT0495","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1530\/EJE-19-0905","article-title":"Abiraterone acetate treatment lowers 11-oxygenated androgens","volume":"182","author":"Wright","year":"2020","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2022011306531787300_CIT0496","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2015-3574","article-title":"Single-dose study of a corticotropin-releasing factor receptor-1 antagonist in women with 21-hydroxylase deficiency","volume":"101","author":"Turcu","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2022011306531787300_CIT0497","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1210\/en.2019-00117","article-title":"A long-acting neutralizing monoclonal ACTH antibody blocks corticosterone and adrenal gene responses in neonatal rats","volume":"160","author":"Gehrand","year":"2019","journal-title":"Endocrinology."},{"issue":"4","key":"2022011306531787300_CIT0498","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11259-018-9737-x","article-title":"Melanocortin 2 receptor antagonists in canine pituitary-dependent hypercortisolism: in vitro studies","volume":"42","author":"Sanders","year":"2018","journal-title":"Vet Res Commun."},{"issue":"3","key":"2022011306531787300_CIT0499","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MED.0000000000000256","article-title":"Novel treatment strategies in congenital adrenal hyperplasia","volume":"23","author":"Turcu","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"issue":"9","key":"2022011306531787300_CIT0500","first-page":"3180","article-title":"The use of adrenalectomy as a treatment for congenital adrenal hyperplasia","volume":"81","author":"Van Wyk","year":"1996","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022011306531787300_CIT0501","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1210\/jc.2018-00217","article-title":"Bilateral adrenalectomy in congenital adrenal hyperplasia: a systematic review and meta-analysis","volume":"103","author":"MacKay","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2022011306531787300_CIT0502","doi-asserted-by":"crossref","first-page":"E2084","DOI":"10.1210\/jc.2012-2298","article-title":"Use of PET\/CT with cosyntropin stimulation to identify and localize adrenal rest tissue following adrenalectomy in a woman with congenital adrenal hyperplasia","volume":"97","author":"Crocker","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"2022011306531787300_CIT0503","first-page":"e675","article-title":"11C-metomidate PET\/CT detected multiple ectopic adrenal rest tumors in a woman with congenital adrenal hyperplasia","volume":"2020","author":"Burman","journal-title":"J Clin Endocrinol Metab."},{"issue":"21","key":"2022011306531787300_CIT0504","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMc1410041","article-title":"Mitotane for 21-hydroxylase deficiency in an infertile man","volume":"371","author":"Bry-Gauillard","year":"2014","journal-title":"N Engl J Med."},{"issue":"8","key":"2022011306531787300_CIT0505","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1210\/clinem\/dgaa381","article-title":"A phase 2, multicenter study of nevanimibe for the treatment of congenital adrenal hyperplasia","volume":"105","author":"El-Maouche","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022011306531787300_CIT0506","first-page":"1511","article-title":"Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia","volume":"86","author":"Quintos","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022011306531787300_CIT0507","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1210\/jc.2010-2699","article-title":"Final adult height in children with congenital adrenal hyperplasia treated with growth hormone","volume":"96","author":"Lin-Su","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022011306531787300_CIT0508","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1210\/jc.2004-2128","article-title":"Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia","volume":"90","author":"Lin-Su","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022011306531787300_CIT0509","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell."},{"issue":"6","key":"2022011306531787300_CIT0510","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11892-017-0863-6","article-title":"Cell therapy for type 1 diabetes: current and future strategies","volume":"17","author":"Aghazadeh","year":"2017","journal-title":"Curr Diab Rep."},{"issue":"10","key":"2022011306531787300_CIT0511","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nbt.1946","article-title":"Direct lineage conversions: unnatural but useful?","volume":"29","author":"Vierbuchen","year":"2011","journal-title":"Nat Biotechnol."},{"key":"2022011306531787300_CIT0512","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fendo.2015.00070","article-title":"New directions for the treatment of adrenal insufficiency","volume":"6","author":"Ruiz-Babot","year":"2015","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"5","key":"2022011306531787300_CIT0513","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.celrep.2018.01.003","article-title":"Modeling congenital adrenal hyperplasia and testing interventions for adrenal insufficiency using donor-specific reprogrammed cells","volume":"22","author":"Ruiz-Babot","year":"2018","journal-title":"Cell Rep."},{"issue":"9","key":"2022011306531787300_CIT0514","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1073\/pnas.84.9.2819","article-title":"Lethal deletion of the complement component C4 and steroid 21-hydroxylase genes in the mouse H-2 class III region, caused by meiotic recombination","volume":"84","author":"Shiroishi","year":"1987","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"11","key":"2022011306531787300_CIT0515","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/sj.gt.3301018","article-title":"Restoration of adrenal steroidogenesis by adenovirus-mediated transfer of human cytochromeP450 21-hydroxylase into the adrenal gland of21-hydroxylase-deficient mice","volume":"6","author":"Tajima","year":"1999","journal-title":"Gene Ther."},{"issue":"10","key":"2022011306531787300_CIT0516","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1507\/endocrj.EJ16-0112","article-title":"Extra-adrenal induction of Cyp21a1 ameliorates systemic steroid metabolism in a mouse model of congenital adrenal hyperplasia","volume":"63","author":"Naiki","year":"2016","journal-title":"Endocr J."},{"issue":"5","key":"2022011306531787300_CIT0517","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/gt.2017.10","article-title":"An AAVrh10-CAG-CYP21-HA vector allows persistent correction of 21-hydroxylase deficiency in a Cyp21-\/- mouse model","volume":"24","author":"Perdomini","year":"2017","journal-title":"Gene Ther."},{"issue":"4","key":"2022011306531787300_CIT0518","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/hum.2017.203","article-title":"Biology of the adrenal gland cortex obviates effective use of adeno-associated virus vectors to treat hereditary adrenal disorders","volume":"29","author":"Markmann","year":"2018","journal-title":"Hum Gene Ther."},{"issue":"11","key":"2022011306531787300_CIT0519","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.socscimed.2011.08.026","article-title":"Hormones, context, and \u201cbrain gender\u201d: a review of evidence from congenital adrenal hyperplasia","volume":"74","author":"Jordan-Young","year":"2012","journal-title":"Soc Sci Med."},{"key":"2022011306531787300_CIT0520","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neubiorev.2020.07.018","article-title":"Human gender development","volume":"118","author":"Hines","year":"2020","journal-title":"Neurosci Biobehav Rev."},{"issue":"1","key":"2022011306531787300_CIT0521","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/cdep.12261","article-title":"Beyond pink and blue: the complexity of early androgen effects on gender development","volume":"12","author":"Berenbaum","year":"2018","journal-title":"Child Dev Perspect."},{"key":"2022011306531787300_CIT0522","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/B978-0-12-416006-4.00023-5","article-title":"Psychoendocrinology of congenital adrenal hyperplasia","volume-title":"Genetic Steroid Disorders","author":"Meyer-Bahlburg","year":"2014"},{"key":"2022011306531787300_CIT0523","doi-asserted-by":"crossref","first-page":"191520","DOI":"10.1186\/1687-9856-2010-191520","article-title":"Congenital adrenal hyperplasia: classification of studies employing psychological endpoints","volume":"2010","author":"Stout","year":"2010","journal-title":"Int J Pediatr Endocrinol."},{"issue":"10","key":"2022011306531787300_CIT0524","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archpediatrics.2011.165","article-title":"The 1990s: a decade of change in understanding children with ongoing conditions","volume":"165","author":"Stein","year":"2011","journal-title":"Arch Pediatr Adolesc Med."},{"key":"2022011306531787300_CIT0525","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4614-7441-8_5","article-title":"A noncategorical approach to the psychosocial care of persons with DSD and their families","volume-title":"Gender Dysphoria and Disorders of Sex Development.","author":"Sandberg","year":"2014"},{"issue":"11","key":"2022011306531787300_CIT0526","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1210\/jc.2018-01863","article-title":"Genital reconstructive surgery in females with congenital adrenal hyperplasia: a systematic review and meta-analysis","volume":"103","author":"Almasri","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2022011306531787300_CIT0527","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/jpepsy\/jst049","article-title":"Parenting stress among caregivers of children with chronic illness: a systematic review","volume":"38","author":"Cousino","year":"2013","journal-title":"J Pediatr Psychol."},{"issue":"8","key":"2022011306531787300_CIT0528","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/jpepsy\/jsp138","article-title":"Risk factors associated with depressive symptoms in caregivers of children with type 1 diabetes or cystic fibrosis","volume":"35","author":"Driscoll","year":"2010","journal-title":"J Pediatr Psychol."},{"issue":"1","key":"2022011306531787300_CIT0529","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1037\/a0027519","article-title":"Paternal involvement in pediatric Type 1 diabetes: fathers\u2019 and mothers\u2019 psychological functioning and disease management","volume":"30","author":"Hansen","year":"2012","journal-title":"Fam Syst Health."},{"key":"2022011306531787300_CIT0530","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1477-7525-6-60","article-title":"Quality of life among adolescents with sickle cell disease: mediation of pain by internalizing symptoms and parenting stress","volume":"6","author":"Barakat","year":"2008","journal-title":"Health Qual Life Outcomes."},{"issue":"4","key":"2022011306531787300_CIT0531","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/jpepsy\/jsr110","article-title":"Families with children with diabetes: implications of parent stress for parent and child health","volume":"37","author":"Helgeson","year":"2012","journal-title":"J Pediatr Psychol."},{"issue":"2","key":"2022011306531787300_CIT0532","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/pbc.21577","article-title":"The relationship of parental overprotection, perceived vulnerability, and parenting stress to behavioral, emotional, and social adjustment in children with cancer","volume":"51","author":"Colletti","year":"2008","journal-title":"Pediatr Blood Cancer."},{"issue":"8","key":"2022011306531787300_CIT0533","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/jpepsy\/jsm044","article-title":"The relationship of parental overprotection, perceived child vulnerability, and parenting stress to uncertainty in youth with chronic illness","volume":"32","author":"Mullins","year":"2007","journal-title":"J Pediatr Psychol."},{"issue":"5","key":"2022011306531787300_CIT0534","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/nur.20452","article-title":"Factors associated with parental perception of child vulnerability 12 months after abnormal newborn screening results","volume":"34","author":"Tluczek","year":"2011","journal-title":"Res Nurs Health."},{"issue":"2","key":"2022011306531787300_CIT0535","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10882-007-9037-9","article-title":"An examination of parenting variables and child self-care behavior across disease groups","volume":"19","author":"Bourdeau","year":"2007","journal-title":"J Dev Phys Disabil."},{"issue":"8","key":"2022011306531787300_CIT0536","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s11136-011-9854-2","article-title":"Quality of life among parents of children with cancer or brain tumors: the impact of child characteristics and parental psychosocial factors","volume":"20","author":"Litzelman","year":"2011","journal-title":"Qual Life Res."},{"issue":"1","key":"2022011306531787300_CIT0537","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1037\/a0014770","article-title":"Nighttime caregiving behaviors among parents of young children with Type 1 diabetes: associations with illness characteristics and parent functioning","volume":"27","author":"Monaghan","year":"2009","journal-title":"Fam Syst Health."},{"issue":"2","key":"2022011306531787300_CIT0538","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bodyim.2012.10.008","article-title":"Body image of children and adolescents with chronic illness: a meta-analytic comparison with healthy peers","volume":"10","author":"Pinquart","year":"2013","journal-title":"Body Image."},{"issue":"2","key":"2022011306531787300_CIT0539","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2214.2012.01397.x","article-title":"Self-esteem of children and adolescents with chronic illness: a meta-analysis","volume":"39","author":"Pinquart","year":"2013","journal-title":"Child Care Health Dev."},{"key":"2022011306531787300_CIT0540","first-page":"1","article-title":"Chronic illness in childhood and early adolescence: a longitudinal exploration of co-occurring mental illness","volume":"4","author":"Brady","year":"2020","journal-title":"Dev Psychopathol."},{"key":"2022011306531787300_CIT0541","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/epirev\/mxr024","article-title":"Peer victimization among school-aged children with chronic conditions","volume":"34","author":"Sentenac","year":"2012","journal-title":"Epidemiol Rev."},{"issue":"5","key":"2022011306531787300_CIT0542","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/cch.12475","article-title":"Understanding the school experiences of children and adolescents with serious chronic illness: a systematic meta-review","volume":"43","author":"Lum","year":"2017","journal-title":"Child Care Health Dev."},{"issue":"9","key":"2022011306531787300_CIT0543","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/jpepsy\/jsr042","article-title":"Behavior problems in children and adolescents with chronic physical illness: a meta-analysis","volume":"36","author":"Pinquart","year":"2011","journal-title":"J Pediatr Psychol."},{"issue":"7","key":"2022011306531787300_CIT0544","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/jcpp.12727","article-title":"Research review: childhood chronic physical illness and adult emotional health - a systematic review and meta-analysis","volume":"58","author":"Secinti","year":"2017","journal-title":"J Child Psychol Psychiatry."},{"key":"2022011306531787300_CIT0545","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.psyneuen.2015.06.017","article-title":"Congenital adrenal hyperplasia and risk for psychiatric disorders in girls and women born between 1915 and 2010: a total population study","volume":"60","author":"Engberg","year":"2015","journal-title":"Psychoneuroendocrinology."},{"issue":"5","key":"2022011306531787300_CIT0546","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/jpepsy\/jsx142","article-title":"Barriers to transition from pediatric to adult care: a systematic review","volume":"43","author":"Gray","year":"2018","journal-title":"J Pediatr Psychol."},{"issue":"4","key":"2022011306531787300_CIT0547","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1177\/1074840717735499","article-title":"How the child\u2019s gender matters for families having a child with congenital adrenal hyperplasia","volume":"23","author":"Fleming","year":"2017","journal-title":"J Fam Nurs."},{"issue":"5","key":"2022011306531787300_CIT0548","first-page":"496","article-title":"Stigma in medical settings as reported retrospectively by women with congenital adrenal hyperplasia (CAH) for their childhood and adolescence","volume":"42","author":"Meyer-Bahlburg","year":"2017","journal-title":"J Pediatr Psychol."},{"issue":"2","key":"2022011306531787300_CIT0549","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10672-011-9177-z","article-title":"Career barriers experienced by people with chronic illness: a U.S. study","volume":"24","author":"Beatty","year":"2011","journal-title":"Empl Responsib Rights J."},{"issue":"1","key":"2022011306531787300_CIT0550","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1687-9856-2011-10","article-title":"Children with disorders of sex development: a qualitative study of early parental experience","volume":"2011","author":"Crissman","year":"2011","journal-title":"Int J Pediatr Endocrinol."},{"issue":"4","key":"2022011306531787300_CIT0551","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10508-017-1003-8","article-title":"Stigma associated with classical congenital adrenal hyperplasia in women\u2019s sexual lives","volume":"47","author":"Meyer-Bahlburg","year":"2018","journal-title":"Arch Sex Behav."},{"key":"2022011306531787300_CIT0552","first-page":"10","article-title":"Stigma associated with classical congenital adrenal hyperplasia in women\u2019s sexual lives","volume":"2017","author":"Meyer-Bahlburg","journal-title":"Arch Sex Behav."},{"key":"2022011306531787300_CIT0553","doi-asserted-by":"crossref","first-page":"980121","DOI":"10.1155\/2015\/980121","article-title":"Parental reports of stigma associated with child\u2019s disorder of sex development","volume":"2015","author":"Rolston","year":"2015","journal-title":"Int J Endocrinol."},{"issue":"10","key":"2022011306531787300_CIT0554","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1515\/JPEM.2006.19.10.1207","article-title":"Living with congenital adrenal hyperplasia in Vietnam: a survey of parents","volume":"19","author":"Armstrong","year":"2006","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"1","key":"2022011306531787300_CIT0555","doi-asserted-by":"crossref","first-page":"e000130","DOI":"10.1136\/bmjpo-2017-000130","article-title":"Social stigmatisation in late identified patients with disorders of sex development in Indonesia","volume":"1","author":"Ediati","year":"2017","journal-title":"BMJ Paediatr Open."},{"issue":"5-6","key":"2022011306531787300_CIT0556","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1515\/jpem-2013-0267","article-title":"Psychological impact on parents of children with congenital adrenal hyperplasia: a study from Sri Lanka","volume":"27","author":"de Silva","year":"2014","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"5","key":"2022011306531787300_CIT0557","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jpag.2020.04.008","article-title":"A multicenter cross-sectional study of Malaysian females with congenital adrenal hyperplasia: their body image and their perspectives on feminizing surgery","volume":"33","author":"Zainuddin","year":"2020","journal-title":"J Pediatr Adolesc Gynecol."},{"issue":"6","key":"2022011306531787300_CIT0558","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jpag.2012.08.004","article-title":"Research on quality of life in female patients with congenital adrenal hyperplasia and issues in developing nations","volume":"26","author":"Zainuddin","year":"2013","journal-title":"J Pediatr Adolesc Gynecol."},{"key":"2022011306531787300_CIT0559","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fped.2019.00144","article-title":"Malaysian females with congenital adrenal hyperplasia: surgical outcomes and attitudes","volume":"7","author":"Zainuddin","year":"2019","journal-title":"Front Pediatr."},{"issue":"5","key":"2022011306531787300_CIT0560","doi-asserted-by":"crossref","first-page":"150840","DOI":"10.1016\/j.sempedsurg.2019.150840","article-title":"The impact of culture on disclosure in differences of sex development","volume":"28","author":"Weidler","year":"2019","journal-title":"Semin Pediatr Surg."},{"key":"2022011306531787300_CIT0561","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1186\/1471-2458-11-745","article-title":"Male gender preference, female gender disadvantage as risk factors for psychological morbidity in Pakistani women of childbearing age - a life course perspective","volume":"11","author":"Qadir","year":"2011","journal-title":"BMC Public Health."},{"issue":"14","key":"2022011306531787300_CIT0562","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1177\/0009922818803407","article-title":"The role of patient advocacy and the declining rate of clitoroplasty in 46,XX patients with congenital adrenal hyperplasia","volume":"57","author":"Schoer","year":"2018","journal-title":"Clin Pediatr (Phila)."},{"issue":"4","key":"2022011306531787300_CIT0563","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/1467-9566.13072","article-title":"\u2018You\u2019re basically calling doctors torturers\u2019: stakeholder framing issues around naming intersex rights claims as human rights abuses","volume":"42","author":"Crocetti","year":"2020","journal-title":"Sociol Health Illn."},{"issue":"5","key":"2022011306531787300_CIT0564","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1055\/s-0035-1547269","article-title":"Ethical issues in decision-making for infants with disorders of sex development","volume":"47","author":"Kon","year":"2015","journal-title":"Horm Metab Res."},{"issue":"3","key":"2022011306531787300_CIT0565","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.ten.0000081687.21823.d4","article-title":"What is the agenda of the intersex patient advocacy movement?","volume":"13","author":"Chase","year":"2003","journal-title":"Endocrinologist."},{"issue":"3","key":"2022011306531787300_CIT0566","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.esxm.2020.03.002","article-title":"Dealing with uncertainty and lack of knowledge in diverse sex development: controversies on early surgery and questions of consent","volume":"8","author":"Lampalzer","year":"2020","journal-title":"Sex Med."},{"issue":"5","key":"2022011306531787300_CIT0567","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1055\/s-0035-1548793","article-title":"Building trust: the history and ongoing relationships amongst DSD clinicians, researchers, and patient advocacy groups","volume":"47","author":"Lossie","year":"2015","journal-title":"Horm Metab Res."},{"issue":"3","key":"2022011306531787300_CIT0568","first-page":"213","article-title":"Disorders of sex development-when and how to tell the patient","volume":"8","author":"Austin","year":"2011","journal-title":"Pediatr Endocrinol Rev."},{"issue":"4-5","key":"2022011306531787300_CIT0569","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/00224499.2019.1578331","article-title":"Intersex or diverse sex development: critical review of psychosocial health care research and indications for practice","volume":"56","author":"Roen","year":"2019","journal-title":"J Sex Res."},{"key":"2022011306531787300_CIT0570","doi-asserted-by":"crossref","first-page":"982025","DOI":"10.1186\/1687-9856-2010-982025","article-title":"Review of outcome information in 46,XX patients with congenital adrenal hyperplasia assigned\/reared male: what does it say about gender assignment?","volume":"2010","author":"Lee","year":"2010","journal-title":"Int J Pediatr Endocrinol."},{"issue":"4 Suppl","key":"2022011306531787300_CIT0571","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.juro.2010.03.116","article-title":"Should male gender assignment be considered in the markedly virilized patient With 46,XX and congenital adrenal hyperplasia?","volume":"184","author":"Lee","year":"2010","journal-title":"J Urol."},{"issue":"10","key":"2022011306531787300_CIT0572","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1210\/jc.2010-0714","article-title":"Approach to assigning gender in 46,XX congenital adrenal hyperplasia with male external genitalia: replacing dogmatism with pragmatism","volume":"95","author":"Houk","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022011306531787300_CIT0573","doi-asserted-by":"crossref","first-page":"150838","DOI":"10.1016\/j.sempedsurg.2019.150838","article-title":"Development of a decision support tool in pediatric differences\/disorders of sex development","volume":"28","author":"Sandberg","year":"2019","journal-title":"Semin Pediatr Surg."},{"key":"2022011306531787300_CIT0574","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13633-016-0040-8","article-title":"Deferring surgical treatment of ambiguous genitalia into adolescence in girls with 21-hydroxylase deficiency: a feasibility study","volume":"2017","author":"Bougn\u00e8res","year":"2017","journal-title":"Int J Pediatr Endocrinol."},{"issue":"5","key":"2022011306531787300_CIT0575","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s10508-014-0385-0","article-title":"Increased cross-gender identification independent of gender role behavior in girls with congenital adrenal hyperplasia: results from a standardized assessment of 4- to 11-year-old children","volume":"44","author":"Pasterski","year":"2015","journal-title":"Arch Sex Behav."},{"issue":"4","key":"2022011306531787300_CIT0576","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10508-005-4338-5","article-title":"Gender dysphoria and gender change in chromosomal females with congenital adrenal hyperplasia","volume":"34","author":"Dessens","year":"2005","journal-title":"Arch Sex Behav."},{"issue":"6","key":"2022011306531787300_CIT0577","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jpurol.2012.09.009","article-title":"Determinant factors of gender identity: a commentary","volume":"8","author":"Liao","year":"2012","journal-title":"J Pediatr Urol."},{"key":"2022011306531787300_CIT0578","first-page":"99","article-title":"Disorders of sex development peer support","volume-title":"Understanding Differences and Disorders of Sex Development (DSD). Endocrine Development.","author":"Baratz"},{"issue":"2","key":"2022011306531787300_CIT0579","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jpurol.2020.02.013","article-title":"Individualized care for patients with intersex (disorders\/differences of sex development): part I","volume":"16","author":"Lee","year":"2020","journal-title":"J Pediatr Urol."},{"issue":"1","key":"2022011306531787300_CIT0580","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13633-015-0004-4","article-title":"Congenital adrenal hyperplasia patient perception of \u2018disorders of sex development\u2019 nomenclature","volume":"2015","author":"Lin-Su","year":"2015","journal-title":"Int J Pediatr Endocrinol."},{"issue":"6","key":"2022011306531787300_CIT0581","doi-asserted-by":"crossref","first-page":"608 e601","DOI":"10.1016\/j.jpurol.2017.04.007","article-title":"Attitudes towards \u201cdisorders of sex development\u201d nomenclature among affected individuals","volume":"13","author":"Johnson","year":"2017","journal-title":"J Pediatr Urol."},{"key":"2022011306531787300_CIT0582","first-page":"1","article-title":"Disorders or differences of sex development? Views of affected individuals on DSD terminology","volume":"2020","author":"Bennecke","journal-title":"J Sex Res."},{"key":"2022011306531787300_CIT0583","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.psyneuen.2015.11.010","article-title":"Reduced short term memory in congenital adrenal hyperplasia (CAH) and its relationship to spatial and quantitative performance","volume":"64","author":"Collaer","year":"2016","journal-title":"Psychoneuroendocrinology."},{"issue":"4","key":"2022011306531787300_CIT0584","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1210\/jc.2005-1959","article-title":"Impaired cognitive function in women with congenital adrenal hyperplasia","volume":"91","author":"Johannsen","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2022011306531787300_CIT0585","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00431-018-3226-7","article-title":"Cognitive function in children with classic congenital adrenal hyperplasia","volume":"177","author":"Hamed","year":"2018","journal-title":"Eur J Pediatr."},{"issue":"6","key":"2022011306531787300_CIT0586","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/cen.13001","article-title":"Experience in optimizing fertility outcomes in men with congenital adrenal hyperplasia due to 21 hydroxylase deficiency","volume":"84","author":"King","year":"2016","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"5","key":"2022011306531787300_CIT0587","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1210\/jc.2008-1414","article-title":"High prevalence of reduced fecundity in men with congenital adrenal hyperplasia","volume":"94","author":"Reisch","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2022011306531787300_CIT0588","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1210\/jc.2017-01139","article-title":"Reduced frequency of biological and increased frequency of adopted children in males with 21-hydroxylase deficiency: a Swedish population-based national cohort study","volume":"102","author":"Falhammar","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022011306531787300_CIT0589","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1365-2265.2009.03563.x","article-title":"Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate","volume":"70","author":"Caster\u00e0s","year":"2009","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"6","key":"2022011306531787300_CIT0590","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1210\/jcem.84.6.5718","article-title":"What causes low rates of child-bearing in congenital adrenal hyperplasia? [Review] [58 refs]","volume":"84","author":"Meyer-Bahlburg","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022011306531787300_CIT0591","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/1367493512443906","article-title":"Informing parents about positive newborn screen results: parents\u2019 recommendations","volume":"16","author":"Salm","year":"2012","journal-title":"J Child Health Care."},{"issue":"5","key":"2022011306531787300_CIT0592","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1530\/EJE-10-0693","article-title":"Psychiatric characterization of children with genetic causes of hyperandrogenism","volume":"163","author":"Mueller","year":"2010","journal-title":"Eur J Endocrinol."},{"key":"2022011306531787300_CIT0593","first-page":"1","article-title":"Quality of life, social situation, and sexual satisfaction, in adult males with congenital adrenal hyperplasia","volume":"2014","author":"Falhammar","journal-title":"Endocrine."},{"issue":"1","key":"2022011306531787300_CIT0594","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12020-018-1723-0","article-title":"Psychological adjustment, quality of life, and self-perceptions of reproductive health in males with congenital adrenal hyperplasia: a systematic review","volume":"62","author":"Daae","year":"2018","journal-title":"Endocrine."},{"issue":"3","key":"2022011306531787300_CIT0595","doi-asserted-by":"crossref","first-page":"E554","DOI":"10.1210\/jc.2013-3707","article-title":"Increased psychiatric morbidity in men with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"99","author":"Falhammar","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0596","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1542\/peds.2006-0738","article-title":"Consensus statement on management of intersex disorders. International Consensus Conference on Intersex","volume":"118","author":"Lee","year":"2006","journal-title":"Pediatrics."},{"issue":"6","key":"2022011306531787300_CIT0597","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10508-006-9068-9","article-title":"Gender development in women with congenital adrenal hyperplasia as a function of disorder severity","volume":"35","author":"Meyer-Bahlburg","year":"2006","journal-title":"Arch Sex Behav."},{"issue":"9","key":"2022011306531787300_CIT0598","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1210\/jc.2009-0636","article-title":"Gender role behavior, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21A2 deficiency","volume":"94","author":"Fris\u00e9n","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2022011306531787300_CIT0599","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1210\/jc.2001-011531","article-title":"Sex-typed toy play behavior correlates with the degree of prenatal androgen exposure assessed by CYP21 genotype in girls with congenital adrenal hyperplasia","volume":"87","author":"Nordenstr\u00f6m","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"2022011306531787300_CIT0600","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/9781119125556.devpsy103","article-title":"Developmental epidemiology","volume-title":"Developmental Psychopathology.","author":"Costello","year":"2016"},{"issue":"4","key":"2022011306531787300_CIT0601","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.euroneuro.2005.04.012","article-title":"Size and burden of mental disorders in Europe \u2013 a critical review and appraisal of 27 studies","volume":"15","author":"Wittchen","year":"2005","journal-title":"Eur Neuropsychopharmacol."},{"issue":"1","key":"2022011306531787300_CIT0602","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12888-018-1647-5","article-title":"Prevalence and stability of mental disorders among young adults: findings from a longitudinal study","volume":"18","author":"Gustavson","year":"2018","journal-title":"BMC Psychiatry."},{"issue":"6","key":"2022011306531787300_CIT0603","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3928\/0090-4481-20030601-10","article-title":"Hidden morbidity in pediatric primary care","volume":"32","author":"Bernal","year":"2003","journal-title":"Pediatr Ann."},{"key":"2022011306531787300_CIT0604","volume-title":"Mental Health in the United States.","author":"Centers for Disease Control and Prevention","year":"2019"},{"issue":"2","key":"2022011306531787300_CIT0605","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ajmg.c.31561","article-title":"Interdisciplinary care in disorders\/differences of sex development (DSD): The psychosocial component of the DSD-Translational research network","volume":"175","author":"Sandberg","year":"2017","journal-title":"Am J Med Genet C Semin Med Genet."},{"key":"2022011306531787300_CIT0606","doi-asserted-by":"crossref","first-page":"692439","DOI":"10.1186\/1687-9856-2010-692439","article-title":"An evidence-based model of multidisciplinary care for patients and families affected by classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"2010","author":"Schaeffer","year":"2010","journal-title":"Int J Pediatr Endocrinol."},{"key":"2022011306531787300_CIT0607","doi-asserted-by":"crossref","first-page":"561526","DOI":"10.1186\/1687-9856-2010-561526","article-title":"The medical home concept and congenital adrenal hyperplasia: a comfortable habitat!","volume":"2010","author":"Witchel","year":"2010","journal-title":"Int J Pediatr Endocrinol."},{"key":"2022011306531787300_CIT0608","first-page":"CD009660","article-title":"Psychological interventions for parents of children and adolescents with chronic illness","volume":"3","author":"Law","year":"2019","journal-title":"Cochrane Database Syst Rev."},{"issue":"8","key":"2022011306531787300_CIT0609","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/jpepsy\/jsu038","article-title":"Systematic review and meta-analysis of psychological interventions to promote treatment adherence in children, adolescents, and young adults with chronic illness","volume":"39","author":"Pai","year":"2014","journal-title":"J Pediatr Psychol."},{"issue":"5","key":"2022011306531787300_CIT0610","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1542\/peds.2014-1909","article-title":"Transition care for children with special health care needs","volume":"134","author":"Davis","year":"2014","journal-title":"Pediatrics."},{"issue":"2","key":"2022011306531787300_CIT0611","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1515\/ijamh-2013-0512","article-title":"A systematic review of transition readiness and transfer satisfaction measures for adolescents with chronic illness","volume":"26","author":"Stinson","year":"2014","journal-title":"Int J Adolesc Med Health."},{"issue":"3","key":"2022011306531787300_CIT0612","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/jsm.12028","article-title":"Severity of virilization is associated with cosmetic appearance and sexual function in women with congenital adrenal hyperplasia: a cross-sectional study","volume":"10","author":"van der Zwan","year":"2013","journal-title":"J Sex Med."},{"issue":"6 Pt B","key":"2022011306531787300_CIT0613","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jpurol.2013.03.013","article-title":"Current practice in feminizing surgery for congenital adrenal hyperplasia; a specialist survey","volume":"9","author":"Yankovic","year":"2013","journal-title":"J Pediatr Urol."},{"issue":"5","key":"2022011306531787300_CIT0614","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jpurol.2018.03.020","article-title":"Feminizing genitoplasties: where are we now?","volume":"14","author":"Jesus","year":"2018","journal-title":"J Pediatr Urol."},{"issue":"3","key":"2022011306531787300_CIT0615","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jpedsurg.2015.10.004","article-title":"Should we question early feminizing genitoplasty for patients with congenital adrenal hyperplasia and XX karyotype?","volume":"51","author":"Binet","year":"2016","journal-title":"J Pediatr Surg."},{"issue":"5","key":"2022011306531787300_CIT0616","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jpurol.2020.06.004","article-title":"Individualized care for patients with intersex (disorders\/differences of sex development): Part 3","volume":"16","author":"Bangalore Krishna","year":"2020","journal-title":"J Pediatr Urol."},{"issue":"5","key":"2022011306531787300_CIT0617","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jpurol.2020.06.026","article-title":"Gender identity: a psychosocial primer for providing care to patients with a disorder\/difference of sex development and their families [individualized care for patients with intersex (Disorders\/differences of sex development): Part 2]","volume":"16","author":"Ernst","year":"2020","journal-title":"J Pediatr Urol."},{"issue":"4","key":"2022011306531787300_CIT0618","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-0029-1233490","article-title":"Congenital adrenal hyperplasia: a critical appraisal of the evolution of feminizing genitoplasty and the controversies surrounding gender reassignment","volume":"19","author":"Braga","year":"2009","journal-title":"Eur J Pediatr Surg."},{"issue":"4","key":"2022011306531787300_CIT0619","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/jwh.2011.3072","article-title":"Applying the female sexual functioning index to sexual minority women","volume":"21","author":"Boehmer","year":"2012","journal-title":"J Womens Health (Larchmt)."},{"issue":"2","key":"2022011306531787300_CIT0620","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.juro.2007.09.079","article-title":"Sexual function and genital sensitivity following feminizing genitoplasty for congenital adrenal hyperplasia","volume":"179","author":"Crouch","year":"2008","journal-title":"J Urol."},{"issue":"2","key":"2022011306531787300_CIT0621","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1210\/jc.2007-0556","article-title":"Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia","volume":"93","author":"Nordenskj\u00f6ld","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"9276","key":"2022011306531787300_CIT0622","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(01)05343-0","article-title":"Objective cosmetic and anatomical outcomes at adolescence of feminising surgery for ambiguous genitalia done in childhood","volume":"358","author":"Creighton","year":"2001","journal-title":"Lancet."},{"issue":"3","key":"2022011306531787300_CIT0623","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1530\/EJE-20-1093","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: gonadal dysfunction in congenital adrenal hyperplasia","volume":"184","author":"Claahsen-van der Grinten","year":"2021","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2022011306531787300_CIT0624","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1210\/jc.2014-4124","article-title":"Clinical outcome, hormonal status, gonadotrope axis, and testicular function in 219 adult men born with classic 21-hydroxylase deficiency. A French National Survey","volume":"100","author":"Bouvattier","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0625","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ecl.2009.01.008","article-title":"Fine tuning for quality of life: 21st century approach to treatment of Addison\u2019s disease","volume":"38","author":"Reisch","year":"2009","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"6","key":"2022011306531787300_CIT0626","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1365-2265.2011.04151.x","article-title":"High frequency of adrenal myelolipomas and testicular adrenal rest tumours in adult Norwegian patients with classical congenital adrenal hyperplasia because of 21-hydroxylase deficiency","volume":"75","author":"Nermoen","year":"2011","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"3","key":"2022011306531787300_CIT0627","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2605.2009.00967.x","article-title":"Testicular adrenal rest tumours in boys, adolescents and adult men with congenital adrenal hyperplasia may be associated with the CYP21A2 mutation","volume":"33","author":"Mouritsen","year":"2010","journal-title":"Int J Androl."},{"key":"2022011306531787300_CIT0628","doi-asserted-by":"crossref","first-page":"583","DOI":"10.12659\/PJR.901986","article-title":"Sonography and magnetic resonance imaging characteristics of testicular adrenal rest tumors","volume":"82","author":"Y\u0131lmaz","year":"2017","journal-title":"Pol J Radiol."},{"issue":"3 Pt 2","key":"2022011306531787300_CIT0629","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.juro.2016.09.072","article-title":"Testicular adrenal rest tumors in boys and young adults with congenital adrenal hyperplasia","volume":"197","author":"Kim","year":"2017","journal-title":"J Urol."},{"issue":"6","key":"2022011306531787300_CIT0630","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/js.2018-00082","article-title":"Extensive bilateral adrenal rest testicular tumors in a patient with 3\u03b2-hydroxysteroid dehydrogenase type 2 deficiency","volume":"2","author":"Lolis","year":"2018","journal-title":"J Endocr Soc."},{"issue":"5","key":"2022011306531787300_CIT0631","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2214\/ajr.172.5.10227495","article-title":"Testicular adrenal rest tissue in congenital adrenal hyperplasia: serial sonographic and clinical findings","volume":"172","author":"Avila","year":"1999","journal-title":"AJR Am J Roentgenol."},{"issue":"3","key":"2022011306531787300_CIT0632","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-0042-123037","article-title":"Long-term consequences of congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency in adolescents and adults","volume":"125","author":"Kim","year":"2017","journal-title":"Exp Clin Endocrinol Diabetes."},{"issue":"1","key":"2022011306531787300_CIT0633","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12020-016-1189-x","article-title":"Clinical perspectives in congenital adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency","volume":"55","author":"Bulsari","year":"2017","journal-title":"Endocrine."},{"issue":"3","key":"2022011306531787300_CIT0634","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s12020-018-01835-3","article-title":"Clinical perspectives in congenital adrenal hyperplasia due to 3\u03b2-hydroxysteroid dehydrogenase type 2 deficiency","volume":"63","author":"Al Alawi","year":"2019","journal-title":"Endocrine."},{"issue":"3","key":"2022011306531787300_CIT0635","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/EJE-07-0201","article-title":"Prevalence of testicular adrenal rest tumours in male children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"157","author":"Claahsen-van der Grinten","year":"2007","journal-title":"Eur J Endocrinol."},{"issue":"7","key":"2022011306531787300_CIT0636","first-page":"3070","article-title":"Long term outcome in adult males with classic congenital adrenal hyperplasia","volume":"86","author":"Cabrera","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022011306531787300_CIT0637","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/rmb2.12068","article-title":"Two cases of reversible male infertility due to congenital adrenal hyperplasia combined with testicular adrenal rest tumor","volume":"17","author":"Tanaka","year":"2018","journal-title":"Reprod Med Biol."},{"issue":"11","key":"2022011306531787300_CIT0638","doi-asserted-by":"crossref","first-page":"E1820","DOI":"10.1210\/jc.2012-3181","article-title":"Testicular adrenal rest tumors develop independently of long-term disease control: a longitudinal analysis of 50 adult men with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency","volume":"98","author":"Reisch","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"2022011306531787300_CIT0639","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fendo.2019.00335","article-title":"The high prevalence of testicular adrenal rest tumors in adult men with congenital adrenal hyperplasia is correlated with ACTH levels","volume":"10","author":"Mazzilli","year":"2019","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"5","key":"2022011306531787300_CIT0640","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.juro.2017.11.122","article-title":"Re: Testicular adrenal rest tumors in boys and young adults with congenital adrenal hyperplasia: M. S. Kim, F. Goodarzian, M. F. Keenan, M. E. Geffner, C. M. Koppin, R. E. De Filippo and P. J. Kokorowski J Urol 2017;197:931-936","volume":"199","author":"Verhees","year":"2018","journal-title":"J Urol."},{"issue":"1","key":"2022011306531787300_CIT0641","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5301\/uro.5000162","article-title":"Leydig cell tumour and giant adrenal myelolipoma associated with adrenogenital syndrome: a case report with a review of the literature","volume":"83","author":"Altieri","year":"2016","journal-title":"Urologia."},{"issue":"3","key":"2022011306531787300_CIT0642","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.fertnstert.2007.03.051","article-title":"Testicular adrenal rest tumors in patients with congenital adrenal hyperplasia can cause severe testicular damage","volume":"89","author":"Claahsen-van der Grinten","year":"2008","journal-title":"Fertil Steril."},{"issue":"3","key":"2022011306531787300_CIT0643","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/EJE-12-0865","article-title":"Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia","volume":"168","author":"Falhammar","year":"2013","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2022011306531787300_CIT0644","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF03343671","article-title":"Pituitary gonadal axis and child rate in males with classical 21-hydroxylase deficiency","volume":"23","author":"J\u00e4\u00e4skel\u00e4inen","year":"2000","journal-title":"J Endocrinol Invest."},{"issue":"5","key":"2022011306531787300_CIT0645","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1046\/j.1365-2265.2002.01645.x","article-title":"Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome","volume":"57","author":"Manoli","year":"2002","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"4","key":"2022011306531787300_CIT0646","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4103\/2230-8210.98018","article-title":"Pubertal development among girls with classical congenital adrenal hyperplasia initiated on treatment at different ages","volume":"16","author":"Kulshreshtha","year":"2012","journal-title":"Indian J Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0647","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1210\/jc.2009-1383","article-title":"Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"95","author":"Bidet","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022011306531787300_CIT0648","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/humupd\/dmx014","article-title":"Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women","volume":"23","author":"Carmina","year":"2017","journal-title":"Hum Reprod Update."},{"issue":"4","key":"2022011306531787300_CIT0649","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2265.1990.tb03887.x","article-title":"The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives","volume":"33","author":"Hague","year":"1990","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"2","key":"2022011306531787300_CIT0650","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2009.06.025","article-title":"The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia","volume":"94","author":"Pall","year":"2010","journal-title":"Fertil Steril."},{"issue":"10","key":"2022011306531787300_CIT0651","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s00330-004-2329-x","article-title":"Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging","volume":"14","author":"Stikkelbroeck","year":"2004","journal-title":"Eur Radiol."},{"issue":"5","key":"2022011306531787300_CIT0652","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/09513590801945230","article-title":"Fertility among women with classical congenital adrenal hyperplasia: report of seven cases where treatment was started after 9 years of age","volume":"24","author":"Kulshreshtha","year":"2008","journal-title":"Gynecol Endocrinol."},{"issue":"12","key":"2022011306531787300_CIT0653","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1093\/humrep\/dez230","article-title":"Breast development and satisfaction in women with disorders\/differences of sex development","volume":"34","author":"van de Grift","year":"2019","journal-title":"Hum Reprod."},{"issue":"8","key":"2022011306531787300_CIT0654","first-page":"687","article-title":"Child rate, pregnancy outcome and ovarian function in females with classical 21-hydroxylase deficiency","volume":"79","author":"J\u00e4\u00e4skel\u00e4inen","year":"2000","journal-title":"Acta Obstet Gynecol Scand."},{"issue":"5","key":"2022011306531787300_CIT0655","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.fertnstert.2017.08.013","article-title":"Fertility outcome and information on fertility issues in individuals with different forms of disorders of sex development: findings from the dsd-LIFE study","volume":"108","author":"S\u0142owikowska-Hilczer","year":"2017","journal-title":"Fertil Steril."},{"issue":"2","key":"2022011306531787300_CIT0656","doi-asserted-by":"crossref","first-page":"e957","DOI":"10.1210\/clinem\/dgaa801","article-title":"Reproductive and perinatal outcomes in women with congenital adrenal hyperplasia: a population-based cohort study","volume":"106","author":"Hirschberg","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"key":"2022011306531787300_CIT0657","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/87565649809540714","article-title":"Early androgen effects on interest in infants: evidence from children with congenital adrenal hyperplasia","volume":"14","author":"Leveroni","year":"1998","journal-title":"Dev Neuropsychol."},{"issue":"4","key":"2022011306531787300_CIT0658","first-page":"933","article-title":"Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency","volume":"76","author":"Helleday","year":"1993","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0659","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2265.1995.tb02034.x","article-title":"Menstrual disturbance and hypersecretion of progesterone in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"43","author":"Holmes-Walker","year":"1995","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"5","key":"2022011306531787300_CIT0660","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.fertnstert.2003.10.024","article-title":"Pregnancies in patients with congenital adrenal hyperplasia with complete or almost complete impairment of 21-hydroxylase activity","volume":"81","author":"Hoepffner","year":"2004","journal-title":"Fertil Steril."},{"issue":"2","key":"2022011306531787300_CIT0661","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.fertnstert.2013.11.002","article-title":"Fertility in patients with congenital adrenal hyperplasia","volume":"101","author":"Reichman","year":"2014","journal-title":"Fertil Steril."},{"issue":"3","key":"2022011306531787300_CIT0662","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ecl.2019.05.011","article-title":"Pregnancy in congenital adrenal hyperplasia","volume":"48","author":"Reisch","year":"2019","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"9","key":"2022011306531787300_CIT0663","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1210\/jc.2006-0062","article-title":"Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia","volume":"91","author":"Moran","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022011306531787300_CIT0664","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/cen.13429","article-title":"Pregnancy in women with nonclassic congenital adrenal hyperplasia: Time to conceive and outcome","volume":"87","author":"Eyal","year":"2017","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"2","key":"2022011306531787300_CIT0665","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/joim.12162","article-title":"Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency","volume":"275","author":"Husebye","year":"2014","journal-title":"J Intern Med."},{"issue":"8","key":"2022011306531787300_CIT0666","doi-asserted-by":"crossref","first-page":"e2853","DOI":"10.1210\/clinem\/dgaa266","article-title":"Current management and outcome of pregnancies in women with adrenal insufficiency: experience from a multicenter survey","volume":"105","author":"Bothou","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022011306531787300_CIT0667","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1365-2265.2001.01359.x","article-title":"Mothers with congenital adrenal hyperplasia and their children: outcome of pregnancy, birth and childhood","volume":"55","author":"Krone","year":"2001","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"9","key":"2022011306531787300_CIT0668","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1210\/JC.2015-2093","article-title":"Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish population-based national cohort study","volume":"100","author":"Falhammar","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0669","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1530\/EJE-14-0978","article-title":"Determining clinical and biological indicators for health outcomes in adult patients with childhood onset of congenital adrenal hyperplasia","volume":"173","author":"Bachelot","year":"2015","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2022011306531787300_CIT0670","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3343\/alm.2015.35.6.578","article-title":"Dried blood spot testing for seven steroids using liquid chromatography-tandem mass spectrometry with reference interval determination in the Korean population","volume":"35","author":"Kim","year":"2015","journal-title":"Ann Lab Med."},{"issue":"11","key":"2022011306531787300_CIT0671","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1210\/jc.2018-01862","article-title":"Cardiovascular and metabolic outcomes in congenital adrenal hyperplasia: a systematic review and meta-analysis","volume":"103","author":"Tamhane","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022011306531787300_CIT0672","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1210\/jc.2006-1350","article-title":"Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"92","author":"Falhammar","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0673","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1530\/EJE-10-0877","article-title":"Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"164","author":"Falhammar","year":"2011","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2022011306531787300_CIT0674","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2265.2009.03690.x","article-title":"Unfavourable trends in cardiovascular and metabolic risk in paediatric and adult patients with congenital adrenal hyperplasia?","volume":"73","author":"Mooij","year":"2010","journal-title":"Clin Endocrinol (Oxf)."},{"key":"2022011306531787300_CIT0675","doi-asserted-by":"crossref","first-page":"383610","DOI":"10.1186\/1687-9856-2009-383610","article-title":"Blood pressure and left ventricular characteristics in young patients with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"2009","author":"Ubertini","year":"2009","journal-title":"Int J Pediatr Endocrinol."},{"issue":"8","key":"2022011306531787300_CIT0676","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1515\/jpem-2019-0079","article-title":"Metabolic profile, cardiovascular risk factors and health-related quality of life in children, adolescents and young adults with congenital adrenal hyperplasia","volume":"32","author":"Vijayan","year":"2019","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"4","key":"2022011306531787300_CIT0677","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/cen.12265","article-title":"Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"80","author":"Subbarayan","year":"2014","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"1","key":"2022011306531787300_CIT0678","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/HJH.0000000000001850","article-title":"Early central blood pressure elevation in adult patients with 21-hydroxylase deficiency","volume":"37","author":"Rosenbaum","year":"2019","journal-title":"J Hypertens."},{"issue":"3","key":"2022011306531787300_CIT0679","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12020-011-9591-x","article-title":"Clinical outcomes in the management of congenital adrenal hyperplasia","volume":"41","author":"Falhammar","year":"2012","journal-title":"Endocrine."},{"issue":"3","key":"2022011306531787300_CIT0680","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1210\/jc.2006-1711","article-title":"Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs, and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"92","author":"Sartorato","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0681","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1210\/jc.2014-1805","article-title":"Cardiovascular abnormalities and impaired exercise performance in adolescents with congenital adrenal hyperplasia","volume":"100","author":"Marra","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0682","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.echo.2017.10.017","article-title":"Complex association of sex hormones on left ventricular systolic function: insight into sexual dimorphism","volume":"31","author":"Salem","year":"2018","journal-title":"J Am Soc Echocardiogr."},{"key":"2022011306531787300_CIT0683","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fendo.2019.00212","article-title":"Cardiovascular health in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxilase deficiency","volume":"10","author":"Improda","year":"2019","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"3","key":"2022011306531787300_CIT0684","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/MED.0000000000000545","article-title":"Long-term cardio-metabolic outcomes in patients with classical congenital adrenal hyperplasia: is the risk real?","volume":"27","author":"Gomes","year":"2020","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"issue":"9","key":"2022011306531787300_CIT0685","doi-asserted-by":"crossref","first-page":"e44893","DOI":"10.1371\/journal.pone.0044893","article-title":"Impact of glucocorticoid receptor gene polymorphisms on the metabolic profile of adult patients with the classical form of 21-hydroxylase deficiency","volume":"7","author":"Moreira","year":"2012","journal-title":"PLoS One."},{"issue":"3","key":"2022011306531787300_CIT0686","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnaa034","article-title":"Considering sex as a biological variable in basic and clinical studies: an Endocrine Society scientific statement","volume":"42","author":"Bhargava","year":"2021","journal-title":"Endocr Rev."},{"issue":"9","key":"2022011306531787300_CIT0687","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.neuropsychologia.2007.01.019","article-title":"Amygdala function in adolescents with congenital adrenal hyperplasia: a model for the study of early steroid abnormalities","volume":"45","author":"Ernst","year":"2007","journal-title":"Neuropsychologia."},{"issue":"4","key":"2022011306531787300_CIT0688","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1210\/jc.2017-01481","article-title":"Quantitative brain MRI in congenital adrenal hyperplasia: in vivo assessment of the cognitive and structural impact of steroid hormones","volume":"103","author":"Webb","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0689","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/088307389701200306","article-title":"Magnetic resonance imaging in the congenital adrenal hyperplasia population: increased frequency of white-matter abnormalities and temporal lobe atrophy","volume":"12","author":"Nass","year":"1997","journal-title":"J Child Neurol."},{"issue":"1","key":"2022011306531787300_CIT0690","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/2230-8210.107833","article-title":"Brain magnetic resonance imaging findings in adult patients with congenital adrenal hyperplasia: Increased frequency of white matter impairment and temporal lobe structures dysgenesis","volume":"17","author":"Mnif","year":"2013","journal-title":"Indian J Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0691","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/a-1247-4651","article-title":"Neuropsychological functioning in patients with Cushing\u2019s disease and Cushing\u2019s syndrome","volume":"129","author":"Siegel","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes."},{"issue":"4","key":"2022011306531787300_CIT0692","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1210\/clinem\/dgaa023","article-title":"Brain differences in the prefrontal cortex, amygdala, and hippocampus in youth with congenital adrenal hyperplasia","volume":"105","author":"Herting","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022011306531787300_CIT0693","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1093\/cercor\/bhz274","article-title":"Altered gray matter structure and white matter microstructure in patients with congenital adrenal hyperplasia: relevance for working memory performance","volume":"30","author":"Van\u2019t Westeinde","year":"2020","journal-title":"Cereb Cortex."},{"issue":"8","key":"2022011306531787300_CIT0694","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/cercor\/bhy109","article-title":"Sex differences in the adult human brain: evidence from 5216 UK biobank participants","volume":"28","author":"Ritchie","year":"2018","journal-title":"Cereb Cortex."},{"issue":"1","key":"2022011306531787300_CIT0695","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/s41598-018-38239-2","article-title":"Novel findings from 2838 adult brains on sex differences in gray matter brain volume","volume":"9","author":"Lotze","year":"2019","journal-title":"Sci Rep."},{"issue":"2","key":"2022011306531787300_CIT0696","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1073\/pnas.1316909110","article-title":"Sex differences in the structural connectome of the human brain","volume":"111","author":"Ingalhalikar","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"4","key":"2022011306531787300_CIT0697","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.neuroimage.2007.03.053","article-title":"Sexual dimorphism of brain developmental trajectories during childhood and adolescence","volume":"36","author":"Lenroot","year":"2007","journal-title":"Neuroimage."},{"issue":"6","key":"2022011306531787300_CIT0698","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"Van Staa","year":"2000","journal-title":"J Bone Miner Res."},{"issue":"10","key":"2022011306531787300_CIT0699","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis","volume":"13","author":"van Staa","year":"2002","journal-title":"Osteoporos Int."},{"issue":"8","key":"2022011306531787300_CIT0700","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41574-020-0341-0","article-title":"Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment","volume":"16","author":"Chotiyarnwong","year":"2020","journal-title":"Nat Rev Endocrinol."},{"issue":"12","key":"2022011306531787300_CIT0701","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1210\/jcem.82.12.4320","article-title":"The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia","volume":"82","author":"Girgis","year":"1997","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0702","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1515\/JPEM.2007.20.2.227","article-title":"Bone mineral status in children with congenital adrenal hyperplasia","volume":"20","author":"Fleischman","year":"2007","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0703","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1210\/jc.2002-021074","article-title":"Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia","volume":"88","author":"Stikkelbroeck","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0704","first-page":"133","article-title":"Normal bone mineral content in young adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"61","author":"Christiansen","year":"2004","journal-title":"Horm Res."},{"issue":"4","key":"2022011306531787300_CIT0705","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1542\/peds.100.4.671","article-title":"Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia","volume":"100","author":"Gussiny\u00e9","year":"1997","journal-title":"Pediatrics."},{"issue":"5","key":"2022011306531787300_CIT0706","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2265.1996.00851.x","article-title":"Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia","volume":"45","author":"Guo","year":"1996","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"4","key":"2022011306531787300_CIT0707","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/meta.2001.21678","article-title":"Preliminary report: effect of adrenal androgen and estrogen on bone maturation and bone mineral density","volume":"50","author":"Arisaka","year":"2001","journal-title":"Metabolism."},{"issue":"4","key":"2022011306531787300_CIT0708","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2265.2008.03518.x","article-title":"Bone mineral density and bone turnover in Romanian children and young adults with classical 21-hydroxylase deficiency are influenced by glucocorticoid replacement therapy","volume":"71","author":"Zimmermann","year":"2009","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"7","key":"2022011306531787300_CIT0709","first-page":"2238","article-title":"Bone mineral density and body composition in congenital adrenal hyperplasia","volume":"80","author":"Cameron","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022011306531787300_CIT0710","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00774-003-0434-6","article-title":"Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross-sectional study of factors involved in bone mineral density","volume":"21","author":"de Almeida Freire","year":"2003","journal-title":"J Bone Miner Metab."},{"issue":"4","key":"2022011306531787300_CIT0711","first-page":"164","article-title":"Height, bone mineral density and bone markers in congenital adrenal hyperplasia","volume":"54","author":"Paganini","year":"2000","journal-title":"Horm Res."},{"issue":"6","key":"2022011306531787300_CIT0712","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1365-2265.1996.8620871.x","article-title":"Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency","volume":"45","author":"J\u00e4\u00e4skel\u00e4inen","year":"1996","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"11","key":"2022011306531787300_CIT0713","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1210\/jc.2005-2823","article-title":"Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency","volume":"91","author":"Sciannamblo","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022011306531787300_CIT0714","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1210\/jc.2005-0745","article-title":"Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia","volume":"91","author":"King","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2022011306531787300_CIT0715","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1210\/jc.2007-0744","article-title":"Fractures and bone mineral density in adult women with 21-hydroxylase deficiency","volume":"92","author":"Falhammar","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022011306531787300_CIT0716","first-page":"268","article-title":"Long-term outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"67","author":"Bachelot","year":"2007","journal-title":"Horm Res."},{"issue":"1","key":"2022011306531787300_CIT0717","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1210\/jc.2011-2036","article-title":"Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy","volume":"97","author":"Koetz","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022011306531787300_CIT0718","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1530\/EJE-16-0104","article-title":"Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"175","author":"Ceccato","year":"2016","journal-title":"Eur J Endocrinol."},{"issue":"4","key":"2022011306531787300_CIT0719","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/cen.14149","article-title":"Bone mineral density and fractures in congenital adrenal hyperplasia: Findings from the dsd-LIFE study","volume":"92","author":"Riehl","year":"2020","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"3","key":"2022011306531787300_CIT0720","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1359\/jbmr.1997.12.3.464","article-title":"Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro","volume":"12","author":"Kasperk","year":"1997","journal-title":"J Bone Miner Res."},{"issue":"3","key":"2022011306531787300_CIT0721","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/cen.12507","article-title":"Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"82","author":"El-Maouche","year":"2015","journal-title":"Clin Endocrinol (Oxf)."},{"key":"2022011306531787300_CIT0722","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3389\/fendo.2020.00493","article-title":"Bone mineral density in adults with congenital adrenal hyperplasia: a systematic review and meta-analysis","volume":"11","author":"Rangaswamaiah","year":"2020","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"11","key":"2022011306531787300_CIT0723","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.4158\/EP-2020-0058","article-title":"Prevalence and characteristics of adrenal tumors and myelolipomas in congenital adrenal hyperplasia: a systematic review and meta-analysis","volume":"26","author":"Nermoen","year":"2020","journal-title":"Endocr Pract."},{"issue":"1","key":"2022011306531787300_CIT0724","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cen.14188","article-title":"Clinical course of adrenal myelolipoma: A long-term longitudinal follow-up study","volume":"93","author":"Hamidi","year":"2020","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"9","key":"2022011306531787300_CIT0725","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S2213-8587(20)30218-7","article-title":"Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study","volume":"8","author":"Bancos","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"2022011306531787300_CIT0726","doi-asserted-by":"crossref","first-page":"6","DOI":"10.15605\/jafes.033.01.02","article-title":"Phenotypic variation of 46,XX late identified congenital adrenal hyperplasia among Indonesians","volume":"33","author":"Juniarto","year":"2018","journal-title":"J ASEAN Fed Endocr Soc."},{"key":"2022011306531787300_CIT0727","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000363672","article-title":"Achieving diagnostic certainty in resource-limited settings","volume":"27","author":"Raza","year":"2014","journal-title":"Endocr Dev."},{"issue":"1","key":"2022011306531787300_CIT0728","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jpsychores.2014.12.007","article-title":"Emotional and behavioral problems in late-identified Indonesian patients with disorders of sex development","volume":"79","author":"Ediati","year":"2015","journal-title":"J Psychosom Res."},{"issue":"6","key":"2022011306531787300_CIT0729","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.jpurol.2014.06.021","article-title":"The challenges in diagnosis and gender assignment in disorders of sex development presenting to a pediatric surgical unit in a developing country: the role of laparoscopy and simple tests for gender identity","volume":"10","author":"Chowdhury","year":"2014","journal-title":"J Pediatr Urol."},{"issue":"3","key":"2022011306531787300_CIT0730","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11154-008-9084-2","article-title":"Disorders of sex development (DSDs), their presentation and management in different cultures","volume":"9","author":"Warne","year":"2008","journal-title":"Rev Endocr Metab Disord."},{"issue":"4","key":"2022011306531787300_CIT0731","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/bdrc.21144","article-title":"Sociocultural aspects of disorders of sex development","volume":"108","author":"Ediati","year":"2016","journal-title":"Birth Defects Res C Embryo Today."},{"issue":"5","key":"2022011306531787300_CIT0732","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s10508-015-0493-5","article-title":"Gender development in Indonesian children, adolescents, and adults with disorders of sex development","volume":"44","author":"Ediati","year":"2015","journal-title":"Arch Sex Behav."},{"key":"2022011306531787300_CIT0733","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fped.2018.00434","article-title":"Quality of life in late-treated patients with disorders of sex development: insights for patient-centered care","volume":"6","author":"Ediati","year":"2018","journal-title":"Front Pediatr."},{"issue":"3","key":"2022011306531787300_CIT0734","first-page":"185","article-title":"Establishing patient registries for rare diseases: rationale and challenges","volume":"34","author":"Boulanger","year":"2020","journal-title":"Pharmaceut Med."},{"key":"2022011306531787300_CIT0735","first-page":"s621","article-title":"Centres of expertise and European reference networks: key issues in the field of rare diseases. The EUCERD recommendations","volume":"12","author":"Taruscio","year":"2014","journal-title":"Blood Transfus."},{"issue":"1","key":"2022011306531787300_CIT0736","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13023-016-0534-8","article-title":"Current models of care for disorders of sex development - results from an International survey of specialist centres","volume":"11","author":"Kyriakou","year":"2016","journal-title":"Orphanet J Rare Dis."},{"issue":"2","key":"2022011306531787300_CIT0737","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/ajmg.c.31558","article-title":"Disorders of sex development (DSD): clinical service delivery in the United States","volume":"175","author":"Rolston","year":"2017","journal-title":"Am J Med Genet C Semin Med Genet."},{"key":"2022011306531787300_CIT0738","doi-asserted-by":"crossref","DOI":"10.1159\/000490081","article-title":"Involving individuals with disorders of sex development and their parents in exploring new models of shared learning: proceedings from a DSDnet COST action workshop","author":"Sanders","year":"2018","journal-title":"Sex Dev."},{"issue":"12","key":"2022011306531787300_CIT0739","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3390\/genes10120978","article-title":"Artificial intelligence (AI) in rare diseases: is the future brighter?","volume":"10","author":"Brasil","year":"2019","journal-title":"Genes (Basel)."}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/advance-article-pdf\/doi\/10.1210\/endrev\/bnab016\/40341284\/bnab016.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/edrv\/article-pdf\/43\/1\/91\/42076562\/bnab016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/edrv\/article-pdf\/43\/1\/91\/42076562\/bnab016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T08:30:20Z","timestamp":1725006620000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/43\/1\/91\/6271518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,7]]},"references-count":739,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,5,7]]},"published-print":{"date-parts":[[2022,1,12]]}},"URL":"https:\/\/doi.org\/10.1210\/endrev\/bnab016","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,1]]},"published":{"date-parts":[[2021,5,7]]}}}